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Emrin Horgusluoglu 
 
NEUROGENESIS IN THE ADULT BRAIN, GENE NETWORKS, AND 
ALZHEIMER’S DISEASE  
 
New neurons are generated throughout adulthood in two regions of the brain, the 
dentate gyrus of the hippocampus, which is important for memory formation and 
cognitive functions, and the sub-ventricular zone of the olfactory bulb, which is 
important for the sense of smell, and are incorporated into hippocampal network 
circuitry. Disruption of this process has been postulated to contribute to 
neurodegenerative disorders including Alzheimer’s disease [1]. AD is the most 
common form of adult-onset dementia and the number of patients with AD 
escalates dramatically each year. The generation of new neurons in the dentate 
gyrus declines with age and in AD. Many of the molecular players in AD are also 
modulators of adult neurogenesis, but the genetic mechanisms influencing adult 
neurogenesis in AD are unclear. The overall goal of this project is to identify 
candidate genes and pathways that play a role in neurogenesis in the adult brain 
and to test the hypotheses that 1) hippocampal neurogenesis-related genes and 
pathways are significantly perturbed in AD and 2) neurogenesis-related pathways 
are significantly associated with hippocampal volume and other AD-related 
biomarker endophenotypes including brain deposition of amyloid-β and tau 
pathology. First, potential modulators of adult neurogenesis and their roles in 
neurodegenerative diseases were evaluated. Candidate genes that control the 
 vi 
turnover process of neural stem cells/precursors to new functional neurons 
during adult neurogenesis were manually curated using a pathway-based 
systems biology approach. Second, a targeted neurogenesis pathway-based 
gene analysis was performed resulting in the identification of ADORA2A as 
associated with hippocampal volume and memory performance in mild cognitive 
impairment and AD. Third, a genome-wide gene-set enrichment analysis was 
conducted to discover associations between hippocampal volume and AD-
related endophenotypes and neurogenesis-related pathways. Within the 
discovered neurogenesis enriched pathways, a gene-based association analysis 
identified TESC and ACVR1 as significantly associated with hippocampal volume 
and APOE and PVLR2 as significantly associated with tau and amyloid beta 
levels in cerebrospinal fluid. This project identifies new genetic contributions to 
hippocampal neurogenesis with translational implications for novel therapeutic 
targets related to learning and memory and neuroprotection in AD. 
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I. Adult neurogenesis and neurodegenerative diseases: A systems 
biology perspective 
 
A. Introduction 
 
New neurons are generated throughout adulthood in two regions of the brain, the 
olfactory bulb and dentate gyrus of the hippocampus, and are incorporated into 
the hippocampal network circuitry; disruption of this process has been postulated 
to contribute to neurodegenerative diseases including Alzheimer’s disease and 
Parkinson disease. Known modulators of adult neurogenesis include signal 
transduction pathways, the vascular and immune systems, metabolic factors, and 
epigenetic regulation. Multiple intrinsic and extrinsic factors such as neurotrophic 
factors, transcription factors, and cell cycle regulators control neural stem cell 
proliferation, maintenance in the adult neurogenic niche, and differentiation into 
mature neurons; these factors act in networks of signaling molecules that 
influence each other during construction and maintenance of neural circuits, and 
in turn contribute to learning and memory. The immune system and vascular 
system are necessary for neuronal formation and neural stem cell fate 
determination. Inflammatory cytokines regulate adult neurogenesis in response 
to immune system activation, while the vasculature regulates the neural stem cell 
niche. Vasculature, immune/support cell populations (microglia/astrocytes), 
adhesion molecules, growth factors, and the extracellular matrix also provide a 
homing environment for neural stem cells. Epigenetic changes during 
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hippocampal neurogenesis also impact memory and learning. Some genetic 
variations in neurogenesis related genes may play important roles in the 
alteration of neural stem cells differentiation into new born neurons during adult 
neurogenesis, with important therapeutic implications.  
 
After the discovery of neurogenesis in the adult human brain, there were many 
studies of adult neurogenesis over two decades to identify the underlying genetic 
and environmental mechanisms. In 1998, the presence of adult-born neurons in 
the dentate gyrus of the human hippocampus had been identified by using cancer 
patients who had received the labelled 5-bromo-2'-deoxyuridine (BrdU) in 
hippocampal neurons [2]. By measuring the concentration of nuclear bomb-test-
derived 14C in genomic DNA in the adult human brain, Spalding and colleagues 
found that  neurons are added in the hippocampus per day corresponding to an 
annual turnover of 1.75% of the neurons within the renewing fraction, with a 
modest decline during aging [3]. Alterations in adult neurogenesis have been 
associated with neurological and psychiatric disorders. Enhanced understanding 
of the contribution of biological processes and genetic factors related to 
neurogenesis could lead to novel therapeutic strategies for neurodegenerative 
disease progression as well as many other conditions.  
 
Numerous intrinsic and extrinsic factors affect the processes of adult 
neurogenesis, including the proliferation of neural progenitor cells, fate 
determination of neural progenitor cell progenies, and the differentiation, 
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migration and maturation of adult neurons. Following these processes, adult–
born neurons integrate into the complex circuitry of the olfactory bulb and 
hippocampus [4, 5]. Since the hippocampus plays a crucial role in the formation 
of episodic and spatial memory and is associated with many neurodegenerative 
diseases [6-8], we focus on hippocampal adult neurogenesis in this review. We 
discuss mechanisms of and interactions between these modulators of adult 
neurogenesis, as well as implications for neurodegenerative disease and current 
therapeutic research. 
 
i. Neurogenesis Role in Cognition 
 
In the mammalian brain, adult neurogenesis occurs in two main regions: the 
dentate gyrus of the hippocampus, which is important for memory formation and 
cognitive functions, and the subventricular zone (SVZ) of the olfactory bulb, 
which is important for the sense of smell [9, 10]. Newborn neurons added to 
hippocampal circuitry during adult neurogenesis are important for the stimulation 
of spatial memory and learning [11, 12]. Spatial memory is defined as pattern 
separation, the ability to discriminate among similar experiences [13]. The 
dentate gyrus and CA3 regions of the hippocampus are implicated in spatial 
memory function and the capacity for pattern separation, and are associated with 
learning new information. These cognitive functions have all been shown to 
decrease with age. Integration of new neurons into the existing hippocampal 
neural circuitry and environmental and behavioral factors modulating adult 
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neurogenesis play important roles in hippocampal-dependent learning and 
memory [14]. 
 
Although there are a number of studies showing adult neurogenesis involvement 
in the formation of spatial memory and learning, the results are somewhat 
controversial. Genetic ablation of GFAP-expressing (GFAP+) neural progenitor 
cells did not impair a hippocampal-dependent learning or memory task, while it 
did inhibit contextual fear conditioning [15]. In contrast, rats treated with the DNA 
methylating agent methylazoxymethanol acetate (MAM) toxin for proliferating 
cells showed a reduction in the formation of newborn neurons in the dentate 
gyrus, which was associated with impaired hippocampal-dependent memory 
formation, but not contextual fear conditioning [16]. 
 
New neurons generated by adult neurogenesis in the granule layer of the dentate 
gyrus within the hippocampus play a crucial role in the development of memory 
and learning [17]. There is delayed maturation of the adult-generated granule 
cells in the dentate gyrus [18]. After one week of differentiation, newborn 
neurons’ apical dendrites reach the molecular layer and their axonal projections 
reach to the CA3 region, and spines form 16 days after division. Dendritic spines 
express glutamate receptors and the TrkB receptor for BDNF on their surface to 
regulate the survival of the spines [19, 20]. Dendritic and axonal outgrowth 
accompany the maturation of the neurons. Spine density increases in the fourth 
week post-division. The hippocampal-dependent Morris water maze test showed 
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that 4-28 days old newborn neurons are required for the formation of long-term 
hippocampus-dependent spatial memory [21]. Differential synaptic connectivity of 
the hippocampus along the septo-temporal axis disrupts the septal and temporal 
connections of the hippocampus and negatively effects learning and memory 
[22]. By two months, structurally-modified highly dynamic and plastic spines are 
regulated by neuronal activity [23]. Synaptic connectivity and excitability of new 
neurons in the adult hippocampus are stimulated by bHLH transcription factors 
such as Neurod1 and Neurod2 during adult neurogenesis and memory formation. 
A recent study showed that Neurod1 overexpression in dividing neural stem cells 
(NSCs) leads to differentiation of the new neurons, and inhibits memory deficits 
and rescues memory impairment in APP/PS1 mice [24]. Adult hippocampal 
neurogenesis is highly involved in memory formation and learning which has 
important implications for neurodegenerative disease.  
 
ii. Cell Types in Adult Neurogenesis 
 
In the adult brain, two important regions where neural stem cells are retained are 
responsible for adult neurogenesis, the SVZ and the subgranular zone (SGZ) of 
the hippocampal dentate gyrus. In the SVZ, B1 cell residues line the border 
between the striatum and lateral ventricle; this subpopulation of cells possesses 
astroglial properties and acts as NSCs. B1 cells give rise to intermediate 
progenitors, which divide and generate the neurons destined for the olfactory 
bulb [25]. Unlike B1 cells in the SVZ, which lie in the ventricular wall and have 
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processes that contact the cerebrospinal fluid (CSF), radial astrocytes in the SGZ 
reside deeper in the brain parenchyma in the granule cell layer of the dentate 
gyrus, which does not have contact with the ventricular system, and act as 
NSCs, also known as type 1 cells. Radial astrocytes generate intermediate 
progenitors (type2a and type 2b cells), which differentiate into type 3 cells, or 
immature granule cells. Radial astrocytes have three main domains. The side of 
the radial astrocytes known as the proximal domain faces the hilus and has 
contact with blood vessels and lateral processes, which also contact the other 
radial astrocytes. The second domain is the intermediate domain, which 
includes the cell body and main shaft. The intermediate domain of the radial 
astrocytes interacts with intermediate progenitor cells and granule cells. This 
second domain is important for cell-cell interactions of NSCs with their progeny 
and for detection of local neural activity and signaling from granule cells. The 
third domain is the distal domain, which is highly branched and contacts with 
other granule cells, axons, and synapses in the molecular layer [26, 27]. Briefly, 
the primary progenitor cells are known as Type-I or B-type cells. They divide to 
produce intermediate stage progenitors (Type-II, Type-III, or D-type cells), which 
then undergo further rounds of cell division to generate post-mitotic immature 
granule neurons. These glutamatergic neurons then integrate into the dentate 
gyrus as functional components of the hippocampal circuitry [28-30]. Regulatory 
signals from the peripheral environment play a crucial role in identifying neural 
progenitor fate to become neurons or astrocytes [31] (Figure 1). 
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Figure 1. Adult neurogenesis in the brain. A) Adult neurogenesis occurs in two 
regions: the subgranular zone (SGZ) and the subventricular zone (SVZ).  B) In 
the SVZ, neural progenitor cells (type B cells) give rise to type C cells, which 
differentiate to neuroblasts (type A cells). Type A cells migrate via the rostral 
migratory stream (RMS) and differentiate into neurons in the olfactory bulb (OB). 
Neuroblasts migrate via the RMS to the olfactory bulb and generate new 
neurons. C) In the SGZ, glial-like radial stem cells known as Type-I cells express 
glial fibrillary acidic protein (GFAP) and nestin. They divide to produce 
intermediate stage progenitors (Type-II cells), which then undergo further rounds 
of cell division to generate neuroblasts and post-mitotic immature granule 
neurons. Type II cells express Sox2, while neuroblast and immature neurons 
express doublecortin (DCX), PSA-NCAM, and calretinin. Mature neurons are 
defined by expression of NeuN.  
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Neural progenitor cells in the SVZ of the lateral ventricle migrate through the 
rostral migratory stream and become granule and perigranular neurons of the 
olfactory bulb, whereas the neural progenitor cells in the SGZ differentiate and 
integrate into the local neural network as granule cells of the hippocampus in the 
adult human brain. [2, 3, 7, 32]. NSCs in the SGZ and SVZ undergo self-renewal 
to provide a lifelong supply for the mature hippocampal dentate gyrus granule 
neurons and olfactory bulb respectively. In both regions, NSCs lead to neural 
progenitor cells, which are limited in proliferation and differentiate into neurons or 
glia [23].  
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Although there are many differences between adult SVZ and SGZ neurogenic 
niches, NSCs in both, like glial radial stem cells in the embryo, express GFAP, 
nestin, and Sox2, and they directly contact blood vessels. There is overlap 
between expression of these markers from different neural cell types and they 
might be responsible for the generation of the heterogeneous neural cell types [4, 
33]. The NSC population in the SVZ generates neurons and oligodendrocytes, 
while the NSC population in the SGZ generates neurons and astrocytes. Adult 
progenitors line the hilar side of the granule cell layer of the dentate gyrus where 
SGZ astrocytes lead to intermediate progenitors.  These progenitors mature into 
granule neurons of the dentate gyrus and send axonal projections to the CA3 
region [34, 35]. GABA plays an important role in progenitor differentiation into 
newborn neurons and regulation of neuronal network activity and synaptic 
integration of proliferation in the SGZ; GABA-releasing neuroblast progeny of the 
SVZ stimulate differentiation through GABAergic synaptic input into progenitor 
cells. [36]. After these progenitors differentiate to immature neurons, the 
dendrites of the newborn dentate gyrus cells become more complex and spread 
deeper into the molecular cell layer [23, 37]  
 
Adult hippocampal neurogenesis begins with the proliferation of neural progenitor 
cells in the SGZ zone. While a small population of neural progenitor cells 
differentiate into glia, most of the neural progenitor cells differentiate into dentate 
granule cells within the hippocampus and undergo the process of morphological 
and physiological maturation, [8, 23].  
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iii. Neurogenesis Role in the Hippocampus 
 
The hippocampus is the most important region for learning and episodic/spatial 
memory. Within the hippocampus, the dentate gyrus provides a steady level of 
neurogenesis throughout life. Intrinsic and extrinsic regulatory factors affect the 
proliferation, differentiation, maturation, fate determination, and survival of 
newborn cells in the dentate gyrus [38]. Pyramidal and granule cells comprise 
most of the cells in the hippocampus. The hippocampus receives a large number 
of sensory inputs uni-directionally from neocortical regions, which leads to the 
regulation of hippocampal formation. The granule cell population in the dentate 
gyrus is smaller than the pyramidal cell population in the CA3 region of the 
hippocampus, encodes the information from the entorhinal cortex, and projects to 
the CA3 region [39-41]. CA3 projects a signal to CA1 that changes the inputs in a 
more linear fashion from the entorhinal cortex to the CA3 region. CA1 
subsequently projects the signal into the subiculum and entorhinal cortex [42]. 
This neuronal signaling flow plays an important role in the formation of memory 
and learning [43]. NSCs in the dentate gyrus also differentiate into the astrocytes 
between the granule cell layer and the hilus, which support hippocampal-
dependent memory function [43]. 
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B. Modulators in Adult Neurogenesis 
 
Recent studies have highlighted five important modulators of neurogenesis, 
including signaling transduction pathways, the vascular and immune systems, 
metabolic factors, and epigenetic regulation (Figure 2) [44-46]. The alteration in 
these modulators during adult neurogenesis may be related to the development 
of neurodegenerative diseases. A more complete understanding of the role and 
function of each modulator in regulating NSC fate and integration as neurons in 
the SGZ and olfactory bulb may provide crucial insights leading to new therapies 
for neurological diseases in humans.  
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Figure 2. Schematic illustration of adult neurogenesis related pathways. 
There are five crucial modulators controlling neural stem cell (NSC) proliferation, 
differentiation, migration, and maintenance during adult neurogenesis: Signaling 
transduction pathways, the vascular and immune systems, metabolic factors, and 
epigenetic regulation. These five modulators are composed of diverse molecules 
and biological pathways and mechanisms acting to control neurogenesis. 
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Modulators of Adult Neurogenesis 
 
i. Signaling Transduction in Adult Neurogenesis 
 
Several essential signaling transduction pathways regulate proliferation and 
differentiation of NSCs, as well as migration and survival of the new-born 
neurons and their integration into the neuronal circuitry network in the adult brain. 
In this section, we discuss key signaling pathways Wnt, Notch, Sonic hedgehog 
(Shh), and Eph:ephrin, which modulate different stages of adult neurogenesis.  
 
Wnt Signaling regulates adult hippocampal neurogenesis on molecular, cellular, 
and behavioral levels. It has been shown that stem cells in the adult 
hippocampus express receptors and signaling molecules that correspond to Wnt 
proteins. Astrocytes and the hilar cells of the dentate gyrus express Wnt-3, and 
promote neuroblast proliferation and neuronal differentiation into hippocampal 
granule neurons through Wnt signaling-mediated activation of NeuroD1 [47, 48]. 
NeuroD1 is required for the survival and the maturation of adult neurons. NSC 
proliferation and cell fate determination is controlled by Wnt signaling in 
hippocampal neurogenesis [49]. In the Wnt signaling pathway, -catenin is 
necessary for the expression of Wnt target genes. The expression level of -
catenin by NSCs in the dentate gyrus of the hippocampus affects proliferation of 
stem cells, as well as axonal and dendritic development. Wnt signaling protects 
neurons from injury by neurotoxins such as amyloid- accumulation in AD. For 
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example, Wnt activation of Protein Kinase C (PKC) inhibits GSK-3activity, 
which plays an important role in the phosphorylation and degradation of 
catenin and inhibits apoptosis of the progenitor cells [47, 50, 51]. Another Wnt 
signaling pathway component, survivin, increases adult neurogenesis in the 
dentate gyrus of the hippocampus during traumatic brain injury [52]. On the other 
hand, it has been shown that the Wnt/-catenin signaling pathway promotes 
neuronal proliferation, but not differentiation, via Disrupted in Schizophrenia 1 
(DISC1), which is an inhibitor of GSK-3, in the adult hippocampus [53]. Yet 
another Wnt family member, Wnt-7A, is activated by the nuclear orphan receptor 
Tlx and enhances proliferation and self-renewal of NSCs via the canonical Wnt 
signaling pathway in adult neurogenesis [54]. To sum up, the canonical Wnt 
signaling pathway, including Wnt-3, Wnt-7A, GSK-3and Tlx, may induce 
progenitor cell proliferation and survival in the dentate gyrus of the hippocampus. 
 
Notch Signaling is important for the maintenance and differentiation of NSCs in 
adult neurogenesis [46, 55]. Notch signaling activates the expression of bHLH 
transcription factors such as Hes1, Hes3, and Hes5, which suppresses 
proneuronal gene expression and promotes maintenance of NSCs by inhibiting 
differentiation of NSCs in the SVZ [56]. Likewise, Notch1 is necessary for the 
self-renewal and maintenance of neural stem and progenitor cells in the dentate 
gyrus of the hippocampus [57]. Notch signaling and EGFR signaling regulate the 
balanced interaction between NSCs’ and progenitor cells’ number and self-
renewal in the SVZ region [58]. Notch signaling is necessary for the maintenance 
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of undifferentiated cells, while EGFR promotes the proliferation and migration of 
progenitor cells [59]. Since Notch1 and EGFR are substrates of ADAM 10, which 
prevents amyloid- production, the well-known hallmark of AD, by proteolysis of 
the alpha site of the amyloid precursor protein (APP), there is strong link between 
Notch signaling and AD pathology as well as hippocampal neurogenesis [60-62]. 
 
There are also connections between Wnt signaling and Notch signaling during 
neurogenesis. FGF2 causes accumulation of -catenin by inhibiting GSK-
3catenin accumulation leads to proliferation and maintenance of NSCs by 
activating LEF/TCF transcription factors. Then, -catenin and Notch1 make a 
complex with anti-neurogenic Hes1 and enhance Hes1 expression, which inhibits 
the differentiation of the progenitor cell population [63]. 
 
Sequential signaling through Notch1 and erbB receptors plays an important role 
in glial cell differentiation [64]. ErbB4 and neuregulin-1 and -2 receptors are 
expressed by immature neuroblasts as well as astrocytes and ependymal cells. 
When ErbB4 binds to neuregulin ligands, it drives progenitor cells proliferation 
and migration of neuroblasts in the SVZ. However, ErbB4 controls the formation 
and maintenance of glial cells and differentiation of glial cells via activation of 
Notch1 signaling from granule cells in the astroglia [64]. As a result, Notch 
signaling is involved in the regulation of NSC proliferation, maintenance, and cell 
fate determination.  
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Sonic Hedgehog Signaling (Shh) plays a crucial role in differentiation of cell 
types and the formation of neurons during adult neurogenesis [65]. Shh receptor 
Patch is expressed by the progenitor cells of the dentate gyrus as well as 
pyramidal cells in the CA1 through CA3, and drives hippocampal formation 
during adult neurogenesis. Shh controls the proliferation of progenitor cells in the 
dentate gyrus during hippocampal neurogenesis [66, 67]. Smoothen (Smo), the 
other Shh receptor, is expressed in the adult hippocampus [68]. Smo knockout 
mice show a significant reduction of proliferation of NSCs and progenitor cells in 
the dentate gyrus of the hippocampus and SVZ [69, 70]. Both Patch1 and Smo 
are located on the primary cilia on the GFAP+ stem/progenitor cells, and primary 
cilia control the proliferation of Type2a progenitor cells without affecting the 
amplification of Type 1 radial NSCs in adult hippocampal neurogenesis, which is 
important for spatial learning [71]. 
 
Eph:ephrin signaling, especially via receptor EphB1-B3 and ligand Ephrin-B1-
B3,  plays an important role in the migration of neuroblasts to the olfactory bulb 
and increases the proliferation of NSCs in the SVZ in adult neurogenesis [72]  
EphB1 is expressed in NSCs in the SGZ and controls proliferation, migration, 
and polarity of the neural/progenitor cells during hippocampal neurogenesis [73]. 
A knockout mice study showed that Ephrin-A2 and Ephrin-A3 inhibit progenitor 
cell proliferation by activating Ephrin-A7-mediated signaling in the SVZ and SGZ 
regions [74]. In addition, Ephrin-B2 is expressed in astrocytes, while 
corresponding EphB4 receptors are expressed in NSCs, and Ephrin-B2:EphB4 
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signaling activates -catenin independently of Wnt signaling and increases the 
regulation of proneuronal transcription factors as well as inducing neuronal 
differentiation of progenitor cells in the dentate gyrus of the SGZ [75, 76] . EphB 
receptors are expressed in dendrites and play roles in the maturation and 
plasticity of synapses, regulating spine and synapse formation [44, 77]. Epha1 
has also been identified as a risk gene for Alzheimer’s disease (AD) [78]. 
Alteration in EphA4 and EphB2 have been shown to cause memory impairment 
in an AD mouse model [79], highlighting the importance of this signaling pathway 
in neurogenesis processes and its relevance to neurodegenerative disease. 
Several signaling pathways including Wnt, Notch, Shh, and Eph:ephrin, regulate 
self-renewal, proliferation, and differentiation of NSCs, as well as migration of 
neuroblasts and integration of newborn neurons in the adult brain. Addressing 
the roles of these crucial signaling mechanisms in NSC regulation and integration 
into hippocampal network circuitry may lead to targeted new therapies for 
currently intractable human neurological disorders. 
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ii. Vascular System and Angiogenesis 
 
The vasculature plays an important role in stem cell niche regulation and 
maintenance in neurogenesis. Angiogenesis, the development of new vascular 
networks with existing vessels, is linked with neurogenesis since angiogenesis is 
stimulated by angiogenic genes expressed in neural progenitor cells [80]. NSCs 
are deliberately distributed around blood cells in the brain to facilitate access to 
circulating signaling molecules, growth factors and nutrients. The vascular beds 
of the SVZ and SGZ support adult neurogenesis. While a three-dimensional 
niche including NSC and transit-amplifying cells resides close to SVZ blood 
vessels and increases the vascular contact to other cells in the SVZ, radial 
astrocyte residues in areas near blood vessels and endothelial cells promote 
neural progenitor stem cell proliferation, neuronal differentiation, and survival by 
expressing pro-angiogenic factors such as FGF, VEGF, IGF-1, which enhance 
neurogenesis and neuroprotection in the SGZ. [81-83]. Angiogenesis and 
neurogenesis are combined in the hippocampus; up to 37% of the cells in the 
SGZ are endothelial precursors. Neural progenitors and angioblasts proliferate 
together in the clusters associated with the microvasculature of the SGZ. The 
cells in this cluster express VEGF receptors, while the tissue surrounding this 
cluster expresses VEGF. Furthermore, newly generated capillaries express 
BDNF, which promotes the recruitment and migration of newborn neurons [84]. 
Exercise induces angiogenesis as well as neurogenesis in the hippocampus by 
increasing the expression of NGF and BDNF [85]. However, more research is 
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needed to elucidate the factors modulating endogenous stem cell mobilization 
out of the stem cell niche. Some studies show that activated microglia and 
astrocytes express cytokines such as MCP-1, SCF, CXCL12, and VEGFA to 
attract NSC migration; NSCs express the compatible receptors CCR2, SCF 
receptor c-kit, CXCR4, and VEGFR, respectively, during disease processes such 
as stroke and brain tumor [86-89]. Additionally, microvessel entorhinal cortex 
cytokine expression profiles show that many growth factors, chemokines, 
adhesion molecules and extracellular matrix proteins such as PDGF-BB, 
RANTES, I-TAC, NAP-2, GROα, Ang-2, and M-CSF are secreted by the 
entorhinal cortex to promote chemo-attraction of NSCs [90]. Many vascular and 
angiogenic factors regulate neurogenesis in the adult brain; better understanding 
of the vascular compartment of the NSC niche may provide therapeutic insights 
for neuronal diseases. 
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iii. Metabolic Factors and Their Role in Adult Neurogenesis 
 
Adult neurogenesis is regulated by metabolic growth factors such as VEGF, 
BDNF, IGF-1, FGF2, IGF and PDGF. As it is mentioned below, these growth 
factors play important roles in neural stem/progenitor cell proliferation, migration, 
cell fate determination and maturation into new neurons. 
VEGF signaling plays an important role in NSC proliferation, survival, and neural 
progenitor migration and maturation [91].  VEGF is a glycoprotein, and is 
necessary for angiogenesis and vascularization. There are four isoforms 
belonging to the VEGF gene: VEGF-A, VEGF-B, VEGF-C and VEGF-D. VEGFA 
is expressed by endothelial cells and the choroid plexus, and regulates NSC 
renewal and progenitor cell migration by binding to the VEGF receptors 
(VEGFR1 and VEGFR2/Flk-1) secreted by the neural stem cell niche [92-94]. 
VEGFA expressed by astrocytes diffuses to the lateral ventricle and has a trophic 
effect on neural progenitor cells, which promotes their survival as well as 
increasing neurogenesis after cerebral ischemia [95]. Therefore, VEGFA/VEGFR 
signaling modulates vascular permeability and angiogenesis [91, 96]. Lastly, 
VEGF-C/VEGFR3 signaling is required for NSC renewal and regulates adult 
neurogenesis. Inhibition of VEGR3 from NSCs causes reduction of neurogenesis 
[97]. 
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BDNF is secreted by endothelial cells to promote neural progenitor cell 
proliferation, differentiation, and survival in adult neurogenesis [98]. NSCs 
express the neurotrophin receptor TrkB, which binds to BDNF and has multiple 
roles in NSC survival and neuronal plasticity [99]. In the SVZ, neuroblasts 
secrete GABA, which induces TrkB expression in astrocytes to catch 
extracellular BDNF, which in turn stimulates neuroblast migration in the rostral 
migratory stream [100]. Besides BDNF, multiple neurotrophic factors such as 
FGF and EGF determine the NSC transition between proliferation and 
differentiation [101, 102].  BDNF/TrkB signaling regulates differentiation and 
survival of neurons and synaptic plasticity by activating Ras/MAP kinase, 
Phospholipase C, and PI3K pathways. BDNF/TrkB signaling also enhances 
hyperphosphorylation of the tau protein, which contributes to AD pathology, while 
BDNF gene expression is elevated in transgenic AD mice via environmental 
enrichment, demonstrating the importance of this neurotrophic factor in 
neurodegenerative disease processes as well as neurogenesis [103]. 
 
IGF-1 upregulation in the bloodstream, induced by exercise, promotes BDNF 
expression in the dentate gyrus, which modulates synaptic plasticity and 
cognitive enhancement [104]. IGF-1 induces the proliferation and differentiation 
of NSCs via MEK/ERK pathway signaling and the PI3K/Akt pathway signaling in 
the SGZ and SVZ, respectively [105]. 
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FGF-2 is the other important endothelial-derived effector of adult neurogenesis. 
FGF-2 modulates NSC renewal and proliferation of the granule cell precursors in 
the dentate gyrus of the hippocampus and the SVZ [106]. While GFAP+ cells, 
astrocytes, and GFAP+ radial glia stem cells express FGF-2 in the SVZ, 
astrocytes express FGF-2 to promote neurogenesis by inducing neural 
progenitor proliferation in the SGZ during neurodegenerative disorders such as 
AD, Parkinson disease (PD) and traumatic brain injury [107, 108]. In addition to 
FGF-2, its receptor FGFR1 is expressed in NSCs in the SVZ and dentate gyrus 
of the hippocampus to enhance NSC proliferation [106]. 
 
EGF is expressed by the microvascular entorhinal cortex, while EGF receptors 
are expressed by type C transit-amplifying cells in the SVZ region. SDF-1 
(CXCL12) stimulates EGFR to increase TypeA neuroblast mobility to migrate 
from the SVZ to the olfactory bulb [109]. Another study showed the association 
between BDNF and EGF; BDNF treatment of EGF-induced cultured human stem 
cells in the SVZ promoted cell proliferation and migration [110]. The combination 
of EGF and FGF-2 neurotrophic factors induced progenitor cell proliferation in 
both the dentate gyrus of the hippocampus and the SVZ region in ischemia-
induced rat brains [111]. 
 
PDGF and PDGF receptors are important for the maintenance of neural 
progenitor cells in adult neurogenesis [112]. GFAP+ B cells in the SVZ express 
PDGFRA, which is necessary for oligodendrocyte formation, though not for 
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neurogenesis. PDGF alone has mitogenic effects on B cells, but inhibits 
neuroblast production. PDGF/PDGFRA signaling modulates the balance 
between oligodendrogenesis and neurogenesis [113].  
As a result, neurotrophic factors mentioned above promote neural 
stem/progenitor cell proliferation, differentiation, and migration through different 
signaling cascades as well as the inhibition of neurodegenerative mechanisms 
for neuronal protection [114, 115].  
 
iv. Immune System and Neurogenesis 
 
Immune mechanisms modulate neural plasticity and behavioral processes in the 
human brain. Physiological and psychological factors are crucial to promote 
immune mechanisms. The alterations of signals between immune, nervous, and 
hormonal systems such as elevation of adrenaline and norepinephrine levels in 
blood modulate synaptic plasticity and neurogenesis [116, 117].  The immune 
system controls communication between the environment and the neurogenic 
niche [31]. Activated microglia and cytokine release as an immune response 
affects adult hippocampal neurogenesis as well as learning and memory [31].  
 
The hippocampus and the immune system are interconnected during injury. Non-
neuronal glial cells such as astrocytes and microglia and the cells around the 
choroid plexus such as T cells and B cells play important roles in immune-
derived remodeling by controlling interactions with the environment, such as 
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exchange of nutrients and other compounds, between the brain and the rest of 
the body, and modulate neural progenitor proliferation and differentiation in the 
adult hippocampus [31]. Microglia cell populations are distributed in the dentate 
hilus and granule cell layer and regulate the apoptosis of newborn cells via 
phagocytosis during hippocampal neurogenesis [118, 119]. Besides non-
neuronal cells and immune cells, identification of the MHC class I molecules in 
uninjured neural cell population confirmed that these molecules play significant 
roles in neurogenesis such as neuronal differentiation and synaptic plasticity 
[116, 120].  
 
It has been shown in an immune-deficient AD mouse model that T cells are 
involved in the regeneration of neural precursor cells in the mature hippocampus 
and maintenance of neuronal plasticity [121]. In contrast, during early stages of 
human development, maternal infections change immune activation by intensely 
increasing inflammatory cytokine levels in the fetus, which leads to behavioral 
abnormalities such as autism, schizophrenia and depression in adulthood [122, 
123]. Furthermore, environmental disruption has been shown to affect immune 
modulators and lead to hippocampal dysfunction by the activation of microglia 
and astrocytes, the accumulation of peripheral leukocytes (i.e. T cells) into 
injured brain region(s), and secretion of cytokines, chemokines, and 
prostaglandins to the site of brain pathology [43, 116, 124, 125]. Inflammatory 
and immune molecules such as cytokines and chemokines have important roles 
in hippocampal neurogenesis and synaptic plasticity throughout the human 
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lifespan [126, 127], as well as an having an important impact on neurological 
disease processes, and further study of this modulator of adult neurogenesis 
may provide important future direction to therapeutic efforts.  
 
The Role of Chemokines in Adult Neurogenesis 
 
Chemokines modulate brain plasticity and vulnerability in the hippocampus [43]. 
There are various central nervous system cells such as microglia, astrocytes, 
endothelial cells, oligodendrocytes, perivascular macrophages and neurons 
which produce cytokines and chemokines under different circumstances [128-
130]. Chemokines induce chemotaxis, which facilitates the migration of 
leukocytes to injured areas [131, 132]. During injury, endothelial cells, astrocytes, 
and microglia cells secrete chemokines across the blood-brain-barrier (BBB), 
which facilitates neuroimmune signaling and recruits immune cells to the injury 
area [133, 134].  
 
Chemokines play significant roles in the migration and development of progenitor 
cells, which express chemokine receptors such as CCR1, CCR2, CCR5, CXCR2, 
CXCR3 and CXCR4 in the dentate gyrus of the hippocampus in the postnatal 
brain [135]. In CXCR4 receptor knockout mice, the number of dividing cells in the 
migratory stream of the hippocampus and the dentate gyrus was dramatically 
reduced because CXCR4 is a receptor for CXCL12 chemokine, which is 
expressed in dividing progenitor cells, and CXCR4/CXCL12 signaling is 
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necessary for progenitor cell population proliferation and movement via the 
migratory stream [136]. In addition, as a neurotransmitter, CXCL12 promotes 
GABAergic transmission by a postsynaptic mechanism. GABAergic transmission 
depends on the synergic release of CXCL12 from neural progenitors in the 
dentate gyrus. As a result, neural progenitor cells receive GABAergic inputs, and 
CXCL12 is necessary for transmission of the GABAergic signal to the dividing 
progenitors [126]. CX(3)CR1 and CX(3)CL1 regulate microglial responses 
modulating glutamate toxicity for neuroprotection and glutamatergic synaptic 
input (transmission) on the neurons in the hippocampus [137]. Chemokines are 
important modulators in hippocampal signaling and synaptic plasticity, which is 
important for learning and memory [138, 139].   
 
The Role of Inflammatory Cytokines in Adult Neurogenesis 
 
Inflammation adversely affects hippocampal neurogenesis and proper function of 
the hippocampus. IL-1, IL-6, and TNF- are the most important pro-
inflammatory cytokines, which play key roles in hippocampal neurogenesis as 
well as memory function. 
 
IL-1 expressed in many immune cells and glia cells as well as neurons, impairs 
proliferation and differentiation of neural precursor cells and decreases NSC 
survival rate in hippocampal neurogenesis. IL-1 is the predominant pro-
inflammatory cytokine in the brain, and negatively correlates with the proliferation 
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of NSCs in the dentate gyrus of the hippocampus [140]. The nuclear factor kappa 
B (NFκB) cascades and mitogen-activated protein kinase (MAPK) as well as 
several transcription factors in the nucleus induce the activation of IL-1 IL-
1receptor signaling [141, 142]. Serum level of IL-1increaseswith depressive 
symptoms and impairs learning and memory function [143, 144]. 
 
IL-6 plays an important role in progenitor cell survival in the dentate gyrus of the 
hippocampus [43]. Overexpression of IL-6 from astrocytes reduces neurogenesis 
in the dentate gyrus of the hippocampus by influencing proliferation, survival, and 
differentiation of progenitor cells [140]. 
 
TNF- inhibits neural progenitor cell proliferation during brain injury, while a 
normal level of TNF-increases neurogenesis by affecting expression of 
neurotrophic factors such as NGF and BDNF [145-147]. Since ischemic stroke 
causes neuronal death in the striatum and the cerebral cortex, neurogenesis 
increases after this insult in the dentate gyrus of the SGZ and the rostral SVZ by 
migration of neuroblasts originating from the SVZ into the damaged striatum 
[148, 149]. In response to ischemia, TNF- produced by the microglia, 
astrocytes, and choroid plexus ependymal cells is upregulated. Similarly, TNF 
receptors such as TNF1 and TNF2 are expressed by glial and neuronal cells in 
response to ischemia. Depending on the TNF receptors, cell death or cell 
proliferation is activated [150, 151]. Proinflammatory cytokines such as IL-1, IL-
6, and TNF- alter hippocampal structural plasticity and neuronal structure via 
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alteration in morphology of the granule cells differentiated from NSCs in the 
dentate gyrus and CA1 during inflammation. 
 
v. Epigenetic Modulators 
 
Epigenetics refers to changes in gene activity not resulting from changes in DNA 
sequence. Changes in DNA methylation, histone modifications and regulation by 
non-coding RNAs have important effects on different neuronal phenotypes [152, 
153]. Proteins with methyl-CpG-binding domains (MBDs) bind methylated DNA 
and regulate gene expression by blocking the binding site for transcription 
factors, while DNA methyltransferases (DNTMs) are directly responsible for 
methylating DNA and silencing gene expression.  MBD-1 has been shown to play 
a crucial role in NSC differentiation [154]. The specific binding of MBD1 to the 
FGF2 promoter decreases FGF2 expression and inhibits the differentiation of 
proliferative neural stem cells during adult neurogenesis [155]. Similarly, 
overexpression of DNA methyltransferases DNMT1 and DNMT3a decreases the 
differentiation and migration of NSCs. Methyl-CpG-binding protein 2 (MeCP2) 
regulates gene expression similarly to MBD1. MeCP2 binds to GFAP and inhibits 
its expression, thus controlling neuronal differentiation and maturation, as well as 
cell fate [153, 156]. DNA-damage-inducible protein 45 alpha (Gadd45a) plays a 
role in DNA demethylation and DNA repair during neurogenesis [157].  Gadd45a 
demethylates neurotrophic factors such as BDNF and FGF-1, which affects self-
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renewal and proliferation of NSCs and promotes neuronal maturation and 
dendritic growth [158-160]. 
 
Histone acetylation is a crucial process for the proliferation and differentiation of 
neural stem cells. HDAC3, HDAC5, and HDAC7 interact with the orphan nuclear 
receptor homologue of the Drosophila tailless gene (Tlx or NR2E1) and 
manipulate NSC self-renewal and proliferation [161]. Other epigenetic 
mechanisms involve non-coding RNAs such as microRNAs. MicroRNAs such as 
Let-7b, miR-9, miR-34a, and miR-184 regulate proliferation of NSCs and 
neuronal differentiation. MiR-137 and miR-132 also regulate synaptogenesis and 
the neuronal network, while miR-34a and miR-125b regulate dendritogenesis and 
spine morphology [162, 163]. All of these epigenetic mechanisms highlight the 
importance of looking beyond the genome to understand the biological 
underpinnings of neurogenesis, which will be crucial to advance the state of 
research in therapeutic efforts to address neurogenesis in neurodegenerative 
disease. Epigenetic changes during neurogenesis have an important impact on 
memory and learning, and can play significant roles in neuropsychiatric disorders 
as well such as depression and schizophrenia [164-166].  
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C. Role of Genetic Variation in Adult Neurogenesis 
 
Many gene expression level changes have been observed during adult 
neurogenesis, as presented in the previous sections; these changes affect NSC 
and progenitor proliferation, maintenance in the adult neurogenic niche, and 
differentiation into mature neurons. Although most of the studies focused on the 
alteration of gene expression during adult neurogenesis, some studies showed 
that genetic variations in adult neurogenesis-related genes affect hippocampal 
structure and memory impairment. For instance, the REST gene, a known 
transcriptional repressor, negatively regulates neuronal differentiation during 
neurogenesis, and nonsynonymous variation in this gene is associated with less 
hippocampal loss and greater cortical thickness in individuals who carry at least 
one minor allele [167-169]. Another important gene related to adult neurogenesis 
is G-coupled protein receptor adenosine receptor A2A (ADORA2A) which plays a 
role in neurite growth. Alteration of the expression level of ADORA2A during 
adult neurogenesis affected neuronal differentiation, migration and maturation of 
new neurons [170, 171]. Variants in the ADORA2A gene differentially influence 
the transfer of information into working memory in homozygous rare genotype 
groups due to alteration of glutamatergicneural transmission [172, 173]. 
Moreover, it has been shown that an ADORA2A antagonist reduced cognitive 
decline and resulted in a protective effect on memory formation in Parkinson’s 
disease, Huntington’s disease and Alzheimer’s disease models. [174, 175]. An 
additional Schizophrenia susceptibility gene, DISC-1, regulates neuronal 
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integration of new neurons from neural progenitors into the adult brain and 
promotes structural plasticity [176]. DISC-1 missense variation leads to a 
reduction of the proliferation of progenitor cells, which alters the balance between 
quiescent and proliferative neural stem cells in a transgenic mouse model [177]. 
A missense mutation in the DISC-1 gene is related to alteration of the 
hippocampal structure by reducing gray matter volume and increases the risk for 
Schizophrenia [178]. As previously discussed, BDNF plays an important role in 
neural progenitor cell proliferation, differentiation and survival; additionally, 
overexpression of BDNF enhances adult neurogenesis by increasing dendritic 
spine density on granule cells.  BDNF polymorphism Val66Met modulates 
integration of neurons in vivo and regulates episodic memory and hippocampal 
physiological activation in humans [179, 180]. Moreover, genetic variation in 
BDNF associated with hippocampal atrophy and cognitive decline have been 
identified using neuroimaging-genetics methods [181]. Pro-inflammatory cytokine 
IL-6 plays an important role in the formation of new neurons and glial cells from 
neural progenitor cells during adult neurogenesis, and IL-6 variations have been 
associated with AD, multiple sclerosis, and severe traumatic brain injury [182-
185]. A single nucleotide polymorphism (SNP) within the GRIN2B gene, which is 
an N-Methyl-D-Aspartate (NMDA) glutamate receptor and  enhances synapse 
maturation and survival of new-born neurons, is strongly associated with 
temporal lobe volume in patients with AD and mild cognitive impairment (MCI) 
[186, 187]. Finally, variation within genes strongly related to adult neurogenesis 
processes in AD such as CHRFAM7A, REST, RELN, BCHE, NCAM1 and 
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ADORA2A have been identified by our colleagues in our laboratory using 
neuroimaging-genetic methods [168, 188-192]. 
To sum up, both expression differences and allelic variations in neurogenesis-
related genes in the human genome may have compensatory advantages or 
confer impairment of biological processes during adult neurogenesis.  
 
D. Adult Neurogenesis and Neurodegenerative Diseases 
 
Over fifty years ago, it was reported for the first time that new neurons are 
generated in the dentate gyrus and SVZ of several species during the adult 
period, and this observation launched a new era of research to understand the 
mechanism of adult neurogenesis in  humans [193]. The important feature of 
adult neurogenesis is that there are many modulators playing roles during NSC 
proliferation, differentiation, migration and survival including genetic, 
transcriptional, and epigenetic factors as well as environmental factors and 
disease status [194]. Neurogenesis is a very important process for synaptic 
transmission and is associated with axonal and dendritic formation. Impaired 
adult neurogenesis in neurodegenerative diseases results in loss of existing 
neurons and reduced capacity for NSC renewal; the putative function of new 
neurons eventually is compromised or lost (Figure 3). The crucial question is how 
neurodegenerative diseases affect adult neurogenesis and in turn how 
alterations in neurogenesis impact pathophysiological mechanisms of 
neurodegenerative disease. We consider five diseases that display symptoms 
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related to hippocampal and olfactory dysfunction, the two main brain regions 
where adult neurogenesis occurs. Parkinson’s disease (PD), AD, Huntington 
disease (HD), and amyotrophic lateral sclerosis (ALS) are neurodegenerative 
diseases, while schizophrenia is a condition with both neurodevelopmental and 
neurodegenerative aspects. 
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Figure 3. Impaired neurogenesis in neurodegenerative diseases. 
Neurodegeneration negatively affects the adult neurogenesis process due to 
alteration of chemokines and cytokines, metabolic factors, and epigenetic 
regulation, as well as impairment of signaling transduction. Alteration of 
chemokines and cytokines impairs neuronal stem cell self-renewal and 
differentiation. Alteration of metabolic factors and epigenetic regulators, and 
defects in signaling transduction molecules, inhibits the proliferation of progenitor 
cells and their differentiation into neuroblasts. The inhibition of newborn neuron 
formation may contribute to cognitive decline. 
 
 
 
 
 
 35 
Parkinson’s disease 
 
PD is a movement disorder with frequent psychiatric complications as well as a 
high prevalence of cognitive impairment [195]. The accumulation of -synuclein 
as the major component of Lewy bodies and Lewy neurites is the pathological 
hallmark of PD [196]. Even though there are some conflicting findings regarding 
how adult neurogenesis affects PD processes, some studies in humans show 
that there is reduced proliferation of NSC progenitors in the SVZ [197, 198]. 
Postmortem human PD brain studies and transgenic PD animal models showed 
that the number of EGF and EGF2 receptor positive cells decrease in the adult 
SVZ, causing impairment of olfactory bulb neurogenesis associated with 
dopaminergic deafferentation [199]. In addition, transgenic PD animal model 
studies revealed that stimulation with neurotrophic factors such as EGF and 
FGF-2 cause massive proliferation and migration of neuroblasts into the SVZ 
region [200-202]. -synuclein accumulation in neurogenic regions where adult 
neurogenesis occurs impairs olfactory bulb formation and hippocampal 
neurogenesis. Selective serotonin uptake inhibitor fluoxetine treatment of PD 
increases levels of neurotrophic factors such as BDNF and GDNF, and rescues 
impaired hippocampal neurogenesis in transgenic PD mice [203].  
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Alzheimer’s disease 
 
AD is the most common form of adult-onset dementia. Patients display 
hippocampal atrophy, memory impairment, and other cognitive and olfactory 
deficits. There are two crucial hallmarks of AD: neurofibrillary tangles caused by 
hyperphosphorylation of the tau protein and amyloid- [204]. 
Currently, there is no approved disease modifying treatment for AD. It has been 
shown in numerous genetic studies that APP, presenilin 1 (PSEN1) and PSEN2 
missense mutations cause familial AD [205]. These mutations result in increased 
amyloid- production and intracellular and extracellular accumulation. Presenilin 
is a catalytic component of -secretase, which cuts APP, and also regulates 
Notch and Wnt signaling mechanisms by sequentially cleaving the Notch 
receptor to generate the Notch Intracellular Domain (NICD) [206, 207]. α-
secretase (ADAM protease) cleaves APP to make sAPP and also cleaves 
Notch-1 and components of EGFR, which, as previously discussed, play 
important roles in adult neurogenesis [60]. Many of the molecular players in AD 
are also modulators of adult neurogenesis. The most important of these, PSEN1, 
modulates NSC differentiation in the adult brain, while sAPP regulates the 
proliferation of NSCs [208, 209]. BDNF/TrkB signaling enhances 
dephosphorylation of the tau protein in AD pathology, while BDNF gene 
expression is elevated in transgenic AD mice via environmental enrichment.  
It is not completely understood how hippocampal neurogenesis is affected by AD 
pathology. However, alterations in the early stage of AD progression such as 
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amyloid- deposition and inflammation impair the maturation of newborn neurons 
and inhibit hippocampal neurogenesis [210]. Since abnormal accumulation of 
amyloid- activates microglia and astrocytes to secrete more inflammatory 
cytokines such as IL-1IL-6, and TNF-which regulate the inflammatory 
response, AD has been proposed as a chronic inflammatory disorder of the 
central nervous system [211-213]. Meta-analysis  of proinflammatory cytokine 
levels in cerebrospinal fluid and peripheral serum have shown significant 
elevation of TNF-α and IL-1β in AD patients; this elevation might reflect activated 
neural progenitor cell proliferation as a compensatory mechanism during 
neurodegeneration [214].  Additional cytokine signaling processes have also 
been linked to neurodegenerative processes; for example, CXCL12/CXCR4 
signaling causes astrocytes in the CA1 to release glutamate neurotransmitter, 
which regulates synaptic integration and neuronal excitability and decreases 
amyloid-deposition [215]. Another signaling process involves MCP-1 and 
CCR2, which are both strongly upregulated in AD patients. Expression of MCP-1 
secreted by macrophages, monocytes, and astrocytes is induced by amyloid-
MCP-1 is known to regulate the migration of neural cells in the dentate gyrus 
toward damaged areas in the brain, suggesting an important function in 
neurodegenerative disease [216, 217]. Furthermore, amyloid-accumulation in 
the brain increases IL-1IL-6, and TNF-as well as transforming growth factor 
(TGF)-secretion, which has a negative effect on NSC proliferation and survival 
and inhibits hippocampal neurogenesis, emphasizing the importance of cytokines 
as a modulator of neurogenesis in neurodegenerative disease [145, 218-220].  
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Huntington’s disease 
 
HD is an autosomal dominant neurodegenerative disorder caused by tri-
nucleotide repeat expansion within the Huntington gene [221, 222]. There is no 
reported dysfunction of hippocampal neurogenesis in HD patients. Although 
there is potential migration of neural stem cells progenitors to the degenerating 
striatum, they do not differentiate to mature neurons, indicating a significant 
downstream effect of this process [222-224]. Transgenic HD mouse model 
studies showed that reduction of the hippocampal progenitor cells was 
associated with diminished CREB signaling and elevated TGF-1 signaling [225]. 
Moreover, it has been found that a D2R antagonist partially enhance adult 
neurogenesis by increasing the proliferation of the neural precursor cells and 
immature neurons in the SGZ region of the HD mice model while a D2R 
antagonist did not have any effect on motor performance [226]. The other study 
showed that mutant HD mice had decreased NeuroD1 in neural progenitors in 
the dentate gyrus of the hippocampus and doublecortin and calretinin expression 
in newborn neurons, as well as impairment of spatial memory. NeuroD1 has a 
crucial effect on proliferation, differentiation and maturation of the neural 
progenitor cells; HD pathology adversely affects the function of NeuroD1 [227, 
228]. Alterations of proteins in HD pathology may impair effective adult 
neurogenesis and cause cognitive impairment.  
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Amyotrophic lateral sclerosis 
 
 ALS is a progressive neurodegenerative disorder caused by the degeneration of 
motor neurons, leading to muscle wasting, paralysis, and difficulty breathing 
[229]. Neural stem cell culture from transgenic ALS mice showed that late stage 
ALS microenvironment impairs the functional capacity of NSCs [230]. There 
reduction in number of proliferative GFAP+ cells in SOD-1 transgenic mice, 
causing dominant form of ALS, in the olfactory bulb of the SVZ, and dentate 
gyrus of the hippocampus. However, in early stages of ALS, neurogenesis was 
preserved and there were no alterations of the NSCs [231]. ALS onset and 
progression promotes de novo neurogenesis with NSC proliferation and 
migration to the spinal cord increasing concomitantly with motor neuron 
degeneration. During disease onset and progression, an ALS-like mouse model 
showed increased expression of CXCR4, which is directly associated with NSC 
migration into the spinal cord, compared to age-matched control mice [232]. In 
addition to several ALS studies, immunohistochemical and histological studies of 
FTLD-ALS patients showed that the number of proliferative neural cells in the 
SVZ increased corresponding to disease progression as a compensatory 
mechanism for neurodegeneration [233]. 
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Schizophrenia 
 
Schizophrenia is a complex mental disorder with a strong genetic background. 
Schizophrenia is associated with impairment of adult neurogenesis by disrupting 
NSC proliferation and migration to the SGZ and SVZ [234, 235]. Cognitive 
impairment in schizophrenia might be related to impairment of adult 
neurogenesis [236]. Several candidate genes have been suggested to play roles 
in adult neurogenesis as well as schizophrenia. Neuregulin (Nrg1)-ERBB 
signaling, altered in schizophrenia, normally promotes the maintenance of radial 
glial cells and their migration to the cerebral cortex by movement of cerebellar 
granule cells, which express neuregulin, along radial glial fibers, which express 
ErbB4 [237-239]. The other important gene significantly associated with 
schizophrenia as well as adult neurogenesis is the disrupted-in schizophrenia 1 
(DISC1) gene [240, 241]. DISC1 knockout rats showed aberrant positioning and 
impaired morphogenesis of newborn neurons in the dentate gyrus of the 
hippocampus [241]. Some genes, such as Wnt, GSK-3and Reelin, play roles in 
neuronal development and proliferation, cell fate determination, cell adhesion 
and migration of NSCs, and are also known to have abnormal function in 
schizophrenia, which suggests that there is a strong link between expression of 
developmental genes with abnormal mechanisms of neurogenesis in 
schizophrenia [242-245].  
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Summary of Adult Neurogenesis and Neurodegenerative Diseases 
 
Each neurodegenerative condition has different effects on NSC fate during adult 
neurogenesis by controlling synaptic plasticity, spine morphology, and axonal 
pathology. Newly generated neurons play critical roles in brain development and 
maintenance in the adult brain. Several genes including PSEN1, MAPT, -
synuclein, SOD-1, and Huntingtin, are the main players in modulating synaptic 
plasticity and brain morphology. Alterations in these genes are linked to 
neurodegenerative diseases and changes in neurogenesis in specific areas such 
as the dentate gyrus of the hippocampus and the SVZ in early stages of 
neurodegenerative diseases. Discovery of the genetic mechanisms underlying 
adult neurogenesis and how neurodegenerative disorders affect new neuron 
formation could significantly inform therapeutic approaches to treat 
neurodegenerative diseases in early stages, when intervention has the most 
potential to prevent long-term dysfunction. 
 
E. Therapeutic Research Focused on Adult Neurogenesis 
 
Adult neurogenesis is defined by the formation of new functional neurons from 
NSCs and their integration into the neuronal circuitry to promote structural 
plasticity. Even though the complete mechanism underlying this process is not yet 
known, hippocampal neurogenesis appears to be critical for the formation and 
maintenance of hippocampal structure as well as memory and learning. Since 
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modulators including signaling transduction, the vascular and immune systems, 
and epigenetic regulation enhance structural and synaptic plasticity during 
maturation of the newly generated neurons from their progenitors, many recent 
studies focus on novel pharmacologic strategies targeting adult neurogenesis and 
identification of biomarkers for human neurogenesis.  
 
One novel therapeutic approach targets inflammatory molecules such as 
chemokines and cytokines known to be related to adult neurogenesis. Activated 
microglia and cytokines released as an immune response enhance neural 
progenitor proliferation, differentiation, and maturation into new neurons during 
adult hippocampal neurogenesis as well as facilitating memory formation and 
learning [31]. Moreover, some cytokines such as IL-6, IL-and TNF- modulate 
neural progenitor cell fate and contribute to neural repair mechanisms during 
neuroinflammation [246]. The development of anti-inflammatory drugs targeting 
inflammatory molecules to preserve adult neurogenesis during chronic 
inflammation may provide novel insights into early stages of neurodegenerative 
diseases. Since neuroinflammation both a key component of AD and other 
neurodegenerative disorders and known to affect adult neurogenesis, it has been 
the focus of several therapeutic approaches. Studies have focused on anti-
inflammatory drugs such as nonsteroidal anti-inflammatory drugs (NSAIDs) and 
glucocorticoid steroids, which target expression of proinflammatory cytokines and 
their complimentary molecules, as treatments for AD patients [247, 248]. These 
approaches have not been successful to date although it is suspected that this 
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may reflect their introduction in later stages of disease after substantial 
degenerative changes have already occurred. 
 
Another therapeutic approach to modulate neurogenesis targets neurotrophic 
factors in AD pathology since there is an imbalance between neurotrophic factors 
in the AD brain. For example, the level of neurotrophic factors such as FGF-2 
and NGF increases to compensate for increasing AD pathology, while the level of 
BDNF decreases in the hippocampus [249, 250]. NGF gene therapy causes NGF 
secretion from autologous fibroblasts into the basal forebrain, leading to 
expression of the neurotrophin receptors by cholinergic neurons and cholinergic 
axonal sprouting in the patients with AD for 10 years after gene transfer [251]. 
Also, it has been shown that neuroproliferation of the immature neurons in the 
dentate gyrus of the SGZ increases in AD patients, though it is not clear whether 
these immature neurons are differentiating into mature neurons [252]. VEGF 
levels significantly increase in cerebrospinal fluid while there is decrease of them 
in serum level in AD patients. [253, 254]. Keilhoff and colleagues found that 
antipsychotics haloperidol and risperidone increased neuronal precursor cell 
proliferation and survival of the new granule cells via VEGF and MMP2 in adult 
schizophrenic rat brain [255]. These factors play crucial roles in the determination 
of cell fate and new neuron formation, and an imbalance of these factors affects 
neurogenesis. The environmental changes in the NSC niche due to the altered 
levels of neurotrophic and neuroinflammatory factors in the hippocampus may 
adversely affect the differentiation of progenitor cells into mature neurons. 
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Further studies are needed to address these factors with regard to possible 
therapeutic strategies.  
 
F. Discussion 
 
Adult neurogenesis is important for structural plasticity of the brain through 
turnover of neural stem cells/precursors to new functional neurons. Even though 
the molecular mechanisms underlying this process remain unclear, adult 
hippocampal neurogenesis plays a significant role in learning and memory 
formation, and it is affected by environmental changes and disease conditions 
[256]. There are multiple modulators that affect the formation of newborn neurons 
such as neurotrophic factors, cytokines and chemokines, epigenetic factors, and 
signaling pathways. Each modulator drives NSC proliferation, differentiation, 
migration and survival in different ways. The alteration of these modulators under 
disease conditions negatively affects cognition and hippocampal structure and 
function. Future studies should also focus on identification of genetic variation 
contributing to neurogenesis in healthy adults as well as in neurodegenerative 
disease; such research has strong translational potential to identify novel 
therapeutic targets. It is crucial for future research to continue to investigate the 
functional role of adult neurogenesis in the normal human brain as well as 
alterations in neurodegenerative diseases. Loss of NSC populations and 
impairment of neuron formation are common hallmarks in neurodegenerative 
diseases such as AD, PD, HD and ALS. Future therapeutic strategies hold 
 45 
promise for stimulation of neuronal plasticity and maintenance of newborn 
neurons in early stages of neurodegenerative diseases, potentially halting or 
reversing clinical symptoms in these common, devastating diseases.  
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II. Targeted neurogenesis pathway-based gene analysis identifies 
ADORA2A associated with hippocampal volume in mild cognitive 
impairment and Alzheimer’s disease 
 
A. Introduction 
 
Adult neurogenesis occurs throughout life in specific regions of the brain in 
humans. In rodents, neural stem cells differentiate to new neurons in several 
regions of the brain, but studies show that adult neurogenesis is limited to the 
dentate gyrus (DG) of the hippocampus and the sub-ventricular zone of the 
olfactory bulb in humans [2, 3, 257]. The hippocampus is the most important 
region of the brain for new learning and episodic/spatial memory. The new 
neurons generated during adult neurogenesis are incorporated into hippocampal 
network circuitry during construction and maintenance of neural circuits and 
contribute to learning and memory [222, 258]. The progenitor cells in DG divide 
periodically, and DG experiences stability in neurogenesis throughout life [259, 
260]. In rodents, neural stem cells (NSCs) in the DG make approximately 8,000 
to 10,000 new neurons per day. However, the proportion of hippocampal 
neurogenesis decline in human is smaller than mice with aging [3, 261]. In 1998, 
the presence of adult-born neurons in the dentate gyrus of the human 
hippocampus had been identified by using cancer patients who had received the 
labelled 5-bromo-2'-deoxyuridine (BrdU) in hippocampal neurons [2]. In adults, 
the annual turnover of stem cells into neurons is 1.75% with a modest decline 
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during aging [3]. By contrast, the estimated annualized hippocampal atrophy rate 
is 1.41% per year for cognitively normal older people and 4.66% for patients with 
AD pathology [262]. Disruption of adult neurogenesis process has been 
postulated to contribute to neurodegenerative diseases including AD. Alterations 
in hippocampal neurogenesis in AD could either provide protection by 
proliferation of neural progenitor cells or cause accelerated neural degeneration 
due to impairment of neuronal networks and synaptic plasticity. Several studies 
in mice have combined structural MRI and histological approaches to investigate 
newborn neurons and neural stem/progenitor cells in neurogenesis-related brain 
regions and found that neurogenesis was associated with increased gray matter 
volume [263]. The relationship between hippocampal volume and adult 
neurogenesis in the human brain has not been studied yet. 
 
Many molecular mechanisms and pathways play a role in the hippocampal 
neurogenesis process , including the proliferation of neural progenitor cells, the 
differentiation, migration, and maturation of adult neurons [260, 264]. Known 
modulators of adult neurogenesis include signaling transduction, vascular and 
immune systems, metabolic factors, and epigenetic regulation [260, 264, 265]. In 
particular, multiple factors such as neurotrophic factors, transcription factors, and 
cell cycle regulators control NSC proliferation, maintenance in neurogenic niche, 
and differentiation into mature neurons; these factors play role in networks of 
signaling molecules that influence each other during construction of neural 
circuits, and contribute to learning and memory (Figure 4).  
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Figure 4. Genes playing roles in stem cells proliferation, differentiation, 
migration, and survival to new neurons during adult neurogenesis process. 
Glial-like radial stem cells (light blue); progenitors (pink); neuroblasts (purple); 
immature neurons (green); mature neurons (blue). 
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Disruption of the neurogenesis process has been postulated to contribute to 
neurodegenerative diseases including AD [266]. However, the mechanisms by 
which AD pathology affects neurogenesis are not completely understood. 
Alterations in the early stages of AD, such as amyloid-β deposition and 
inflammation, may impair the maturation of newborn neurons and inhibit 
hippocampal neurogenesis [210]. Genetic changes in neurogenesis-related 
pathways and genes may also play important roles in the alteration of NSCs 
maturation into newborn neurons [260]. Pathway- or gene-based association 
analysis has been used to study a number of complex neurodegenerative 
diseases, including AD, using a wide variety of phenotypes, including 
cerebrospinal fluid Aβ1-42 peptide level [267, 268], cerebral amyloid deposition 
[269], brain glutamate levels [270], and episodic memory [192]. However, no 
study to date has evaluated the association between candidate neurogenesis-
related genes and hippocampal volume. Thus, the goal of the present study was 
to perform a gene-based association analysis of neurogenesis pathway-related 
candidate genes in cognitively normal and impaired participants from ADNI 
cohort. Identification of genes that play a role in both hippocampal neurogenesis 
and AD may hold great promise for better understanding the role of neurogenesis 
in AD, as well as to aid in discovery of novel therapeutic targets for AD. 
 
We used well-characterized participants from extensively studied cohort 
Alzheimer’s Disease Neuroimaging Initiative (ADNI), which uniquely have GWAS 
data sets on the same participants as well as multi-modal structural and 
 51 
functional neuroimaging (MRI, PET) data. A quantitative phenotype approach to 
genetic association studies provides the advantage of increased power sizes to 
detect significant genetic effects as compared to a traditional case-control 
design. We used hippocampal volume as a quantitative phenotype measured by 
MRI imaging, metabolic activity and amyloidosis in the hippocampus measured 
by PET imaging, and composite memory scores as quantitative traits to 
investigate that adult hippocampal neurogenesis-related genes and pathways are 
significantly associated with AD-related endophenotypes.  
 
Highlights: 
 Candidate pathways and genes which play a role in neurogenesis in the 
adult brain are manually-curated. 
 ADORA2A is significantly associated with hippocampal volume 
 A SNP (rs9608282) upstream of ADORA2A is associated with larger 
hippocampal volume and better memory performance. 
 rs9608282 may have a protective effect on brain structure and function in 
neurogenesis-related brain regions. 
 There is a significant interaction effect of NMDA-receptor antagonist use 
and the ADORA2A rs9608282-T on memory performance. 
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B. Materials and Methods 
 
Study Participants 
 
We used the participants of the Alzheimer's Disease Neuroimaging Initiative 
Phase 1 (ADNI-1) and its subsequent extensions (ADNI-GO/2) for this study. 
ADNI was launched in 2004 by the National Institute on Aging, the National 
Institute of Biomedical Imaging and Bioengineering, the Food and Drug 
Administration (FDA), private pharmaceutical companies, and nonprofit 
organizations as a public-private partnership. The aim of ADNI has been to 
identify whether serial MRI, positron emission tomography (PET), sensitive and 
specific other markers, and clinical and neuropsychological assessments could 
be combined to measure the progression of mild cognitive impairment (MCI) and 
early AD. Participants aged 55-90 in ADNI cohort include approximately 400 
cognitively normal older individuals (CN), 100 individuals with significant memory 
concerns (SMC), 800 individuals diagnosed with MCI, and 300 individuals 
diagnosed with AD. Clinical and neuroimaging procedures and the other 
information about the ADNI cohort can be found at http://www.adni-info.org/.  
After the initial analysis, a meta-analysis was conducted with ADNI [271, 272] 
and two independent datasets, including the AddNeuroMed study (N=218; 66 
CN, 77 MCI, 76 AD) [271, 273], and the Indiana Memory and Aging Study (IMAS) 
study (N=59; 29 CN, 24 MCI, 6 AD) [271]. 
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Written informed consent was obtained from each participant and all protocols 
were approved by each participating study and site’s Institutional Review Board. 
 
Subject selection 
 
Only non-Hispanic Caucasian participants were selected for this analysis by 
genetic clustering with CEU (Utah residents with Northern and Western 
European ancestry from the CEPH collection) and TSI (Tuscans in Italy) 
populations using HapMap 3 genotype data and multidimensional scaling (MDS) 
analysis after performing standard quality control (QC) procedures for genetic 
markers and participants [190]. Overall, 1,563 non-Hispanic Caucasian 
participants were included, as their genome-wide association study (GWAS) data 
passed the above population stratification and all other standard QC procedures 
[268]. Demographic information is shown in Table 1 for these participants.   
 
Table 1. Demographic and clinical characteristics of ADNI participants 
 CN SMC EMCI LMCI AD 
N 367 94 280 512 310 
Age 
74.59 
(5.57) 
71.77 
(5.65) 
71.14 
(7.26) 
73.52 
(7.65) 
74.65 
(7.79) 
Gender 
(M/F) 
192/175 38/56 158/122 318/194 176/134 
Education 
16.32 
(2.68) 
16.81 
(2.57) 
16.08 
(2.67) 
15.97 
(2.91) 
15.23 
(2.97) 
APOE 
( 
267/99 62/32 160/119 232/280 104/206 
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Identification of candidate genes 
 
Candidate genes which control the turnover process of neural stem 
cells/precursors to new functional neurons during adult neurogenesis were 
manually curated using a pathway-based systems biology approach (Figure 4). 
Genes from known modulators of adult neurogenesis include those involved in 
signaling transduction, vascular and immune system function, metabolic factors, 
and epigenetic regulation [112, 264, 265, 271, 274]. Pathway-based approaches 
were used to manually curate these hippocampal neurogenesis-related genes 
through a review of existing databases and literature mining, resulting in a final 
gene list (Figure 5). Specifically, we identified hippocampal neurogenesis-related 
genes using four publicly available databases (GoGene, Qiagen RT2 Profiler 
PCR Arrays, Gene Ontology (GO) with Gene Set Enrichment Analysis (GSEA), 
and Mammalian Adult Neurogenesis Gene Ontology (MANGO)) and literature 
mining.  
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Figure 5. Venn diagram of adult neurogenesis-related genes and AD-
susceptibility genes.  Manually curated neurogenesis and AD related gene. 
{(GoGene) U (Mango) U (Qiagen) U (GSEA)} ∩ {Pubmed Mining} = 401.  
AD-susceptibility genes (N=680) from AlzGene database and large-scale GWAS 
results. Eighty-one common genes were identified associated with both 
neurogenesis and AD. U: Union; ∩: Intersection. 
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GoGene contains high-quality manual annotation with high-throughput text 
mining from literature using ontology terms. This database includes associations 
between genes and gene-related terms for ten model organisms extracted from 
more than 18,000,000 Pubmed entries that cover process, function, location of 
genes and their relationship with diseases and compounds 
(http://gopubmed.org/gogene) [275]. We performed a search for GoGene term 
“adult neurogenesis” to identify neurogenesis-related genes.  
 
Qiagen RT2 Profiler PCR Arrays are the one of the most reliable tools to analyze 
the expression of genes related to specific pathways. The human Neurogenesis 
RT² Profiler™ PCR Array contains 84 genes, manually curated using literature 
mining, which are highly related to the process of neurogenesis, such as neural 
stem/progenitor cells proliferation, differentiation, migration, and maturation into 
newborn neurons (www.qiagen.com). Growth factors, inflammatory cytokines, 
cell adhesion molecules, and cell signaling genes involved in the neurogenesis 
process were also represented in this profiling array. We included all genes from 
this Neurogenesis array in our gene list.  
 
DAVID (the Database for Annotation, Visualization, and Integrated Discovery) is 
a publicly available functional tool which includes annotations from Gene 
Ontology (GO). Gene Set Enrichment Analysis (GSEA) pathway annotations 
were downloaded from Molecular Signatures Database version 5.0 
(http://software.broadinstitute.org/gsea/msigdb). This annotation data comprised 
 57 
a collection of GO. A GO annotation contains a GO term associated with a 
specific reference which expresses the target or analysis associated with a 
specific gene product. Each GO term belongs to molecular function [276], cellular 
component (CC), or biological process (BP). “Neurogenesis” was used as the 
GO term in this analysis to identify neurogenesis related gene sets from the 
GSEA database.  
 
We also used MANGO, which consists of 259 genes designed and curated by 
Overall et al. [277]. In MANGO, all genes are classified by their positive, 
negative, or neutral effect on hippocampal neurogenesis and thusly annotated. 
We used recently updated MANGO version 3.1 to annotate genes.  
We identified 510 genes from GoGene, 84 genes from Neurogenesis RT² 
Profiler™ PCR Array, 259 genes from MANGO database, and 93 genes from 
GSEA/Molecular Signatures Database. We combined all genes related to 
neurogenesis from the four databases (N=748). Then, each gene related to 
hippocampal neurogenesis was annotated from relevant literature. Initial Pubmed 
search using the keywords “adult hippocampal neurogenesis” for papers 
published until 9/2016 included 2,717 articles. We used Pubmed to identify if all 
748 genes are related to hippocampal neurogenesis from 2,717 articles.  After 
literature mining, among 748 genes, only 401 genes were related to adult 
hippocampal neurogenesis.  
 
Finally, since a key goal was to identify candidate genes playing a role in both 
adult hippocampal neurogenesis and AD pathology, we focused on hippocampal 
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neurogenesis-related genes which are also implicated in AD. For this purpose, 
we identified AD-associated susceptibility genes using the AlzGene database 
(http://www.alzgene.org/), which provides a comprehensive meta-analysis of 
genes previously identified in various AD association studies, and large-scale AD 
GWAS results (N=680) (Lambert, Ibrahim-Verbaas et al. 2013). The AlzGene 
database consists of a comprehensive, unbiased, publicly available catalog of all 
genetic association studies in the field of AD, which was identified from published 
papers by pubMed search using keywords “alzheimer* AND (genet* OR 
associat*)”. The gene list in AlzGene represents a summary of promising AD 
candidate genes. We then compared this gene list to the 401 genes previously 
identified as involved in adult hippocampal neurogenesis to filter the lists to 81 
common genes related to both hippocampal neurogenesis and AD. These 81 
genes were used in the association analysis. 
 
Endophenotypes  
 
Pre-processed baseline 1.5T and 3T MRI scans from 1,563 participants were 
downloaded from ADNI public website (http://adni.loni.usc.edu). FreeSurfer 
version 5.1 was used to extract total hippocampal and hippocampal subfield 
volumes, as well as total intracranial volume (ICV) [278-281]. Total hippocampal 
volume, as well as selected adult neurogenesis-related subfield volumes (CA1, 
CA23, CA4, and DG) (N=1,563), were used as endophenotypes for the 
association analysis. In addition, we used a composite score of episodic memory 
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(N=1,563) [282] and CSF total tau levels (N=1,112) as endophenotypes to further 
characterize neurodegeneration [283, 284].  
 
Genotyping and Quality Control 
 
ADNI samples were genotyped using Human 610-Quad, HumanOmni Express, 
and HumanOmni 2.5M BeadChips. Sample and SNP quality control procedures 
of GWAS data such as SNP call rate < 95%, Hardy-Weinberg equilibrium test p < 
1 × 10−6, and frequency filtering (MAF ≥ 5%) were performed [190, 285-287]. 
Imputation of un-genotyped SNPs was performed using MaCH (Markov Chain 
Haplotyping) software based on the 1000 Genomes Project as a reference panel 
[288].  
 
Association Analysis and Meta-Analysis 
 
SNPs from the 81 candidate genes were located in untranslated regions [44], 3′ 
UTR, 5′ UTR, coding regions, intronic regions, and regulatory regions (±20 kb of 
upstream and downstream regions).  A gene-based association analysis of 
hippocampal neurogenesis pathway-related candidate genes was performed in 
an additive genetic model using a set-based test in Plink v1.07 
(http://pngu.mgh.harvard.edu/~purcell/plink/) [286]. After frequency and 
genotyping pruning, 18407 SNPs remained from 81 genes. [286]. After frequency 
and genotyping pruning, 18407 SNPs remained from 81 genes. A mean test 
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statistic for each SNP within a gene was computed to determine other SNPs in 
linkage disequilibrium (LD; i.e., r2>0.5). A quantitative trait analysis (QT) was then 
performed with each SNP. For each gene (set), the top independent SNPs (i.e., 
not in LD; maximum of 5) were selected if their p-values were less than 0.05 in 
the QT analysis. The SNP with the smallest p-value was selected first; 
subsequent independent SNPs were selected in order of decreasing statistical 
significance. From these subsets of SNPs, the statistic for each set was 
calculated as the mean of these single SNP statistics. The analysis was 
performed to estimate the additive effect of the selected SNP minor allele on the 
phenotypic mean [269, 286]. Covariates included gender, age, years of 
education, ICV, MRI field strength (1.5T vs 3T) and diagnosis status. An 
empirical p-value (20,000 permutations) was reported for each gene. In the 
discovery sample (ADNI-1/GO/2), a conservative significance threshold (p < 
0.00061) was used based on Bonferroni correction for 81 genes. We 
subsequently performed a meta-analysis for genes and SNPs associated with 
hippocampal volume using data from the ADNI-1/GO/2, AddNeuroMed, and 
IMAS cohorts. The gene-based meta-analysis was performed using the weighted 
z statistic test (Stouffer’s weighted z statistic) as implemented in R, with weight 
accounting for the sample size of each cohort. For SNP-based meta-analysis, 
METAL was used with a fixed-effect inverse variance model [289]. For meta-
analysis, effect sizes were provided by standardized β coefficients from linear 
regression. 
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We also evaluated the effect of the minor allele rs9608282-T on hippocampal 
volume and composite memory score after the participants, which included only 
those diagnosed with MCI or AD, were classified as either a Memantine user 
(NMDA (+)) or a Memantine non-user (NMDA (-)) using two-way analysis of 
covariance (ANCOVA) for continuous variables and a chi-square for categorical 
variables implemented in SPSS 23.0. In addition, two-way analysis of covariance 
(ANCOVA) was used to examine the effect of the minor allele (rs9608282-T) on 
hippocampal volume in both amyloid-negative and amyloid-positive participants 
(classified as positive or negative by either baseline [18F]Florbetapir PET scans 
and/or CSF Aβ1-42 level). 
 
Image analysis 
 
Non-Hispanic Caucasian participants from the Alzheimer’s Disease 
Neuroimaging Initiative GO/2 (ADNIGO/2) cohort with arterial spin labeling (ASL) 
perfusion imaging (N=220) and genotype data were used. Statistical Parametric 
Mapping 8 (Wellcome Trust Centre for Neuroimaging) with a cluster threshold of 
25 voxels was used to perform voxel-wise analysis of the effect of rs9608282-T 
variant in the ADORA2A gene on CBF. Age, sex and diagnosis were used as 
covariates. 
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Gene expression  
 
We examined mRNA expression profiles of the 81 manually-curated adult 
neurogenesis genes in normal brain tissues from the Allen Human Brain Atlas 
(Allen Institute for Brain Science, Seattle, WA; available from http://www.brain-
map.org/). The Allen Human Brain Atlas (AHBA) provides publicly available 
online data sets including extensive gene expression information for the human 
brain. The AHBA gene expression data contains information for approximately 
62,000 gene probes with 93% of known genes represented by at least 2 probes 
for each gene (~30,000 genes) from ~500 brain samples from each hemisphere 
representing cortical, subcortical, cerebellar, and brainstem regions. We 
examined the identified adult neurogenesis-related genes for their expression 
levels in five brain regions related to hippocampal neurogenesis, including CA1, 
CA2, CA3, CA4 and DG. We used a heat map tool to visualize the microarray 
data for the selected neurogenesis-related genes and brain regions across tissue 
samples. 
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C. Results 
 
Gene-based and SNP-based analysis of mean volumes of hippocampus 
and hippocampal sub-regions 
 
The manual gene/pathway curation for hippocampal neurogenesis yielded 18407 
SNPs in 81 genes (Figure 5). In the discovery sample, the gene-based 
association analysis showed that APOE and ADORA2A were significantly 
associated with hippocampal volume after Bonferroni correction (p-value=5x10-5, 
respectively; Table 2).  
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Table 2. 81 genes of gene-based association results in the discovery 
sample for hippocampal volume using common variants (MAF ≥ 0.05) 
where empirical p-values were calculated using 20,000 permutations in 
PLINK. 
 
 
 
Gene 
 
Number 
of SNPs 
in gene 
Number of 
significant 
SNPs 
(p<0.05, 
r2<0.5) 
 
Empirical 
gene-based     
p-value 
 
 
List of significant SNP 
ADORA2A 55 1 5 x 10-5 rs9608282 
APOE 85 5 5 x 10-5 rs429358|rs7259620| 
rs34095326|rs4803770| 
rs157580 
TLR4 58 2 1.5 x 10-2 rs11789302|rs10759930 
BCHE 201 4 2.8 x 10-2 rs2686409|rs1355538| 
rs12107166|rs6807910 
CXCL10 42 1 4.8 x 10-2 rs4256246 
S100B 220 1 6.0 x 10-2 rs118078026 
CXCL12 306 4 6.2 x 10-2 rs11238990|rs11238991| 
rs1144472|rs17659345 
TET1 387 3 0.06593 rs113716271|rs1277658
6|rs12221107 
BCL2 368 5 0.07493 rs9957149|rs28564323| 
rs7236090|rs6567334| 
rs11872403 
PTGS2 52 2 0.08492 rs7547677|rs2206593 
ACHE 51 2 0.08791 rs13245899|rs73714210 
SORL1 233 2 0.09091 rs9665907|rs643010 
SLC6A4 63 1 0.09191 rs16965628 
GRIN2B 1054 5 0.0999 rs34870448|rs11612709|
rs12582848|rs11611667|
rs2300256 
NGFR 86 5 0.0999 rs584589|rs11466150| 
rs2072444|rs535717| 
rs2537710 
MEF2C 232 1 0.1019 rs1065861 
CXCL1 39 1 0.1039 rs2968710 
NR3C1 238 5 0.1209 rs4912912|rs17209237| 
rs10050756|rs7719514| 
rs12653301 
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DKK1 40 2 0.1249 rs11001581|rs7100461 
GRN 37 1 0.1319 rs114641762 
CHAT 189 5 0.1379 rs885834|rs11101179| 
rs1720367|rs4615945| 
rs74981858 
CHRNB2 39 5 0.1499 rs9616|rs9427094| 
rs12072348|rs67860750| 
rs4845653 
SYN3 1388 5 0.1718 rs2157188|rs9609643| 
rs2710348|rs180958069|
rs5749521 
CCL2 43 1 0.1758 rs111843487 
IGF1 89 4 0.1888 rs1549593|rs10860862| 
rs12821878|rs80280982 
VEGFA 59 3 0.1908 rs9381248|rs3025006| 
rs699946 
NGF 135 2 0.1978 rs6537860|rs4320778 
MIF 77 1 0.2008 rs738807 
IL6 77 2 0.2338 rs2069840|rs62449498 
CASP3 94 2 0.2378 rs4647634|rs2696059 
MMP9 57 2 0.2537 rs73112805|rs3918253 
PRNP 94 2 0.2747 rs6052766|rs67017873 
SNCA 444 1 0.2927 rs187644542 
CDK5 53 2 0.3147 rs4148853|rs34403003 
IL1B 42 1 0.3147 rs3917381 
ADAM10 232 1 0.3197 rs544282 
NOS3 71 1 0.3197 rs12666075 
NRG1 2784 5 0.3227 rs147179882|rs2466068|
rs7829383|rs2347071| 
rs11998153 
APBB1 119 1 0.3487 rs11040880 
LRRK2 360 3 0.3526 rs189800607| 
rs10878411|rs11564173 
OLIG2 123 2 0.3626 rs17632819|rs76708155 
NOS1 559 5 0.3826 rs67313272|rs4767542| 
rs816284|rs12228022| 
rs10850829 
HIF1A 82 1 0.4186 rs12891737 
FGF1 221 5 0.4326 rs1808258|rs2070715| 
rs249925|rs10041541| 
rs13179022 
TGFB1 131 1 0.5135 rs4803459 
IGF1R 520 5 0.5325 rs11631965|rs4966039| 
rs3743254|rs7166348| 
rs2272037 
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FAS 175 1 0.5774 rs12767306 
APP 554 5 0.6214 rs2829960|rs6516705| 
rs13046930|rs6516715| 
rs117104544 
NTRK2 605 4 0.6264 rs17087710|rs28580203|
rs1047896|rs1006446 
DYRK1A 380 1 0.6593 rs28550863 
ESR2 412 4 0.6983 rs1152576|rs4986938| 
rs10146107|rs12587140 
RELN 1552 5 0.7932 rs2299373|rs3819491| 
rs39377|rs1476446| 
rs694894 
ESR1 810 1 0.7972 rs55650062 
ABCA2 61 0 1 N/A 
ADRA2A 27 0 1 N/A 
BDNF 122 0 1 N/A 
CAV1 129 0 1 N/A 
CDK5R1 24 0 1 N/A 
CHRNA7 2 0 1 N/A 
CNTF 29 0 1 N/A 
FOS 48 0 1 N/A 
GSK3B 329 0 1 N/A 
HTR2A 203 0 1 N/A 
NEUROD1 54 0 1 N/A 
NPY 131 0 1 N/A 
PLCG1 60 0 1 N/A 
PSEN1 154 0 1 N/A 
SIRT1 98 0 1 N/A 
THRA 82 0 1 N/A 
TNF 40 0 1 N/A 
TNFR1A 4 0 1 N/A 
TNFR1B 54 0 1 N/A 
DLD 24 0 1 N/A 
GLP1R 98 0 1 N/A 
IFNG 19 0 1 N/A 
PLAU 30 0 1 N/A 
PSEN2 19 0 1 N/A 
SOD2 5 0 1 N/A 
TP53 5 0 1 N/A 
CST3 92 0 1 N/A 
CHRM1 47 0 1 N/A 
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One SNP (rs9608282) upstream of ADORA2A was most significantly associated 
with total hippocampal volume and sum of the hippocampal sub-region volumes 
(p = 1.14x10-5 and 2.5x10-4, respectively; Table 3). Specifically, participants with 
no copies of the minor allele (N=1,317; GG genotype) had a smaller mean 
hippocampal volume compared to participants with one copy of the minor allele 
(N=236; TG genotype) or participants with two copies of the minor allele (N=10; 
TT genotype).  
 
Table 3. Association of rs9608282 in ADORA2A with neuroimaging 
phenotypes and memory composite scores with and without diagnosis 
(DX) adjustment. SNP-based association results (p-values) in the discovery 
sample for hippocampal volume, neurogenesis-related hippocampal sub-regions, 
memory performance, and CSF total tau level. 
 
rs9608282 p-value after  
adjusting for DX 
p-value before 
adjusting for DX 
Hippocampal Volume 3.29 x 10-4 1.14 x 10
-5
 
Neurogenesis-Related 
Hippocampal  
Sub-regions 
 
4.55 x 10
-3
 
 
2.50 x 10
-4
 
Memory Composite 
Score 
0.218  7.45 x 10
-3
 
CSF Total Tau 0.2  2.3 x 10
-2
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For replication of our major significant SNP finding, we analyzed independent 
samples from the ADNI, AddNeuroMed IMAS cohorts. SNP-based meta-analysis 
of ADORA2A in three independent cohorts (ADNI1/GO/2, AddNeuroMed, and 
IMAS) identified that rs9608282-T in ADORA2A are significantly associated with 
hippocampal volume (p = 0.000043, N=1,840, Table 4; p = 7.88x10-6, N= 1,840, 
Table 5, respectively). In ADNI1/GO/2, AddNeuroMed cohorts except IMAS, 
rs9608282-T exhibited a positive direction of effect on hippocampal volume. 
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Table 4. Meta-analysis of ADORA2A with hippocampal volume in three 
independent cohorts: ADNI, AddNeuroMed and IMAS. 
 
 
ADNI 
p-value 
AddNeuroMed 
p-value 
IMAS 
p-value 
Meta-analysis 
p-value 
ADORA2A 5x10
-5
 2.1 x 10
-1
 2.95 x 10
-1
 4.3 x 10
-5
 
 
 
Table 5. Meta-analysis of rs9608282 with hippocampal volume in three 
independent cohorts: ADNI, AddNeuroMed and IMAS.  
 
 
rs9608282 
 
N 
Effect of rs9608282 
(T) 
( value) 
 
p-value 
ADNI 1563 146.9 1.14 x 10
-5
 
AddNeuroMed 218 362.4 2.344 x 10
-2
 
IMAS 59 -263.2 4.59 x 10
-2
 
Meta-analysis 1840  7.88 x 10-6 
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Following the SNP-based association analysis, we performed a post-hoc analysis 
to measure the interaction effect of APOE and the ADORA2A SNP on 
hippocampal volume. There was no evidence of epistasis, modeled as interaction 
between APOEstatus and the minor allele of rs9608282 (p = 0.54). However, 
ADORA2A rs9608282-T and APOEexhibited independent but opposite effects 
on hippocampal volume (Figure 6A, 6B), with a comparable effect sizes between 
the APOE allele and the presence of at least one copy of the minor allele at 
rs9608282. Participants carrying at least one copy of the minor allele of the 
ADORA2A SNP have larger hippocampal volumes than those without the minor 
allele, even in participants with APOE ε4 (p = 0.001; Fig. 3C). The positive effect 
of the ADORA2A rs9608282-T allele on hippocampal volume was seen in both 
amyloid-negative and amyloid-positive participants (classified as positive or 
negative by either baseline [18F]Florbetapir PET scans and/or CSF Aβ1-42 level). 
Specifically, rs9608282-T was significantly associated with larger hippocampal 
volumes in Aβ negative (p-value = 0.027) and Aβ positive participants (p-value = 
0.015, Figure 7). In addition, the association of the rs9608282-T allele with 
hippocampal volume and neurogenesis-related to sub-regions independent of 
diagnosis suggests that this effect might be a global phenomenon.  
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Figure 6. APOE ε4 and rs9608282 (ADORA2A) appear to exhibit 
independent, but opposite effect on hippocampal volume. Baseline 
hippocampal volume (adjusted for age, gender, ICV, MRI field strength) ± 
standard errors are shown based on (a) rs9608282 in ADORA2A (A2aR)  
across genotype groups. Presence of at least one copy of the minor allele (T) 
of rs9608282 was significantly associated with increased hippocampal volume  
(p = 0.002). Baseline hippocampal volume is also shown by (b) the number  
of APOE ε4 allele copies. Presence of at least one copy of the ε4 allele was 
significantly associated with decreased hippocampal volume (p < 0.0001).  
(c) For participants having APOE ε4 allele copies,  participants carrying minor 
allele of rs9608282 had larger hippocampal volume than those who did not carry 
minor allele of the ADORA2A rs9608282 (p = 0.001). 
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Figure 7. ADORA2A rs9608282 is associated with larger hippocampal 
volume in amyloid-positive participants (classified by PET scan and/or 
CSF-amyloid beta level). For statistical analysis, each participant was classified 
by their amyloid status (positive versus negative) at the baseline visit (determined 
by standard cutoffs on [18F]Florbetapir PET scan and/or CSF amyloid level). The 
effect of the T allele on hippocampal volume was present in both amyloid-
negative (left column) and amyloid-positive (right column) participants. Upon 
statistical analysis, rs9608282 is significantly associated with  
hippocampal volume in amyloid-negative and even amyloid-positive participants 
(p = 0.027, p = 0.015, respectively). 
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Since previous studies have suggested that ADORA2A plays an important role 
controlling NMDA-dependent synaptic toxicity and memory impairment [290-292], 
we examined the interaction of taking Memantine, a NMDA-receptor antagonist, 
and ADORA2A rs9608282 on hippocampal volume and memory performance. 
Participants diagnosed with MCI or AD were classified as either a Memantine 
user (NMDA+) or a Memantine non-user (NMDA-). We found that NMDA- 
participants carrying at least one copy of the minor allele (T) of the ADORA2A 
rs9608282 had a larger mean hippocampal volume (p<0.001; Figure 8A). There 
was a significant interaction effect of NMDA-receptor antagonist use and 
ADORA2A rs9608282 on memory performance (p = 0.009). NMDA+ participants 
carrying two copies of the major allele (G) of the ADORA2A rs9608282 had 
better memory performance (Figure 8B).  
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Figure 8. ADORA2A rs9608282 is associated with larger hippocampal 
volume in Memantine non-users (NMDA (-)) and poorer memory 
performance in Memantine users (NMDA (+)). For statistical analysis, 
cognitively impaired participants were classified as either a Memantine user 
(NMDA (+)) or a Memantine non-user (NMDA (-)). (A) The rs9608282 T allele 
was associated with a larger mean hippocampal volume in Memantine non-user 
participants (p < 0.001). (B) Participants carrying at least one copy of minor allele 
(T) of the ADORA2A rs9608282 variant and using a NMDA-receptor antagonist 
had poorer memory performance. 
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Association of rs9608282 with episodic memory and CSF level of total tau 
  
Given the association of ADORA2A rs9608282-T with larger hippocampal 
volume, we hypothesized that ADORA2A would also associated with episodic 
memory scores as they are highly related to hippocampal structure. As might be 
hypothesized, rs9608282-T was significantly associated with a better composite 
memory score (= 0.065; p = 0.015) after controlling for age, gender, and years 
of education (Figure 9). 
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Figure 9. Association of memory composite score with rs9608282 in 
ADORA2A across genotype. Baseline memory composite score (adjusted for 
age, gender and education) ± standard errors are displayed based on rs9608282 
genotype. Individuals with a TT genotype at the rs9608282 variant showed a 5% 
increase in memory performance relative to those with a GG genotype. 
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A previous study suggested that hyperphosphorylated tau decreases adult 
neurogenesis in mouse model [293]. Therefore, we also assessed the effect of 
the rs9608282-T minor allele on CSF total tau level. As we hypothesized, 
rs9608282-T carriers showed decreased CSF total tau levels relative to non-
carriers (= -0.061; p = 0.039), after controlling for age and gender (Figure 10). 
However, there is no correlations of rs9608282 with CSF Aand phospho-tau 
levels. 
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Figure 10. Association of CSF tau level with rs9608282 in ADORA2A  
across genotype. CSF total tau level (adjusted for age and gender) ± standard 
errors are displayed based on rs9608282 genotype. Individuals with a TT 
genotype at the rs9608282 variant showed significant decrease in CSF tau level 
relative to those with a GG genotype. 
 
 
 
 
 
  
 79 
Association of rs9608282 with cerebral blood flow 
 
Since selective blockade of the adenosine A2A receptor reduced the pial 
vasodilation in certain situations, we tested the hypothesis that rs9608282 in 
ADORA2A is significantly associated with cerebral blood flow (CBF). Voxel-wise 
analysis of ASL perfusion demonstrated significantly decreased regional CBF 
especially in the left cerebrum, temporal lobe, and superior temporal gyrus in 
individuals with at least one minor alleles (T) of rs9608282 compared to those 
with no minor allele (Figure 11). 
 
Figure 11. Individuals with at least one minor alleles (T) of rs9608282 
associated with perfusion decrease 
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Finally, we used gene expression data from the Allen Human Brain Atlas to 
evaluate if ADORA2A was expressed in neurogenesis-related regions in normal 
brains. ADORA2A was in fact highly expressed across the major adult 
neurogenesis related regions of the brain (Figure 12) and was especially highly 
expressed in CA1 and CA2.  
 
Figure 12. ADORA2A expression profiles across the hippocampus region. 
The square dot indicates the tissue sample location for human brain. In each 
square, heat map color represents the z-score over a probe ranging from green 
(z-score of -3 and below) through black to red (z-score of +3 and above). Red 
squares represents overexpression of the ADORA2A in specific locations, most 
especially in CA1 and CA2. 
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D. Discussion 
 
We used well-characterized participants from the extensively studied cohort 
Alzheimer’s Disease Neuroimaging Initiative (ADNI), which uniquely includes 
participants with cognitively normal older individuals (CN), significant memory 
concerns (SMC), mild cognitive impairment (MCI), and Alzheimer’s Disease 
(AD). Using targeted neurogenesis pathway-based gene analysis, we discovered 
a significant association of ADORA2A rs9608282-T with larger mean 
hippocampal volumes and volumes of neurogenesis-related hippocampal sub-
regions, better episodic memory performance, and reduced CSF total tau. These 
findings suggested a protective effect of this SNP on brain structure and function 
in neurogenesis-related brain regions.  
ADORA2A (Adenosine Receptor Subtype A2a) is a G-protein-coupled adenosine 
receptor that is involved with controlling synaptic plasticity in glutamatergic 
synapses [294, 295]. Previous work had indicated a physical and functional 
interaction of ADORA2A with dopamine D2 receptors [296]. However, A1R–A2AR 
heteromer controls the affinity of agonist binding to A2a receptors in the striatum 
and localizes in glutamatergic nerve terminals to control glutamate release [297]. 
In addition to its abundance in the striatum, ADORA2A also plays an important 
role in hippocampus, particularly in neurogenesis in the CA3 region. A previous 
study demonstrated that inhibition of the A2a receptor induced synaptic damage 
in rat hippocampal nerve terminals [298].  
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A reduction of A2a receptors in mice with traumatic brain injury has also been 
shown to decrease cognitive impairment [299]. In fact, the adenosine 2a receptor 
localizes in microglial cells and may be a regulation of microglial function in 
response to brain damage [294]. Since neuroinflammatory blockade is thought to 
enhance neural stem/progenitor cells activity and promote adult neurogenesis, 
A2a receptor-mediated control of neuroinflammation might be a vital mechanism 
in neurodegenerative diseases [218]. Inhibition of the A2a receptor also prevents 
early A-induced synaptotoxicity and memory dysfunction through a p38 MAPK-
dependent pathway [300], potentially suggesting additional roles for this receptor 
in AD. In fact, ADORA2A blockade prevented memory decline secondary to 
amyloid-beta accumulation, which is a major pathological hallmark in AD [301]. 
Another important role of ADORA2A is to modulate brain-derived neurotrophic 
factor (BDNF). Administration of an ADORA2A antagonist inhibits the actions of 
BDNF on GABA and glutamate release from the hippocampal nerve terminals 
[302].  In addition, the A2a receptor is involved with control of N-methyl-D-
aspartate (NMDA) receptor function by co-localizing with metabotropic glutamate 
5 receptors (Glu5R) in hippocampal synapses [292]. The synaptic localization of 
A2a receptors plays a key role controlling NMDA-dependent synaptic 
transmission in the hippocampus [303]. In fact, glutamate release is dependent 
on the activation of adenosine A2AR by endogenous adenosine [300, 302]. 
Previous studies showed the relationship between NMDA receptor and 
Adenosine Receptor Subtype A2a, which supports our finding of a significant 
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interaction effect of NMDA-receptor antagonist use and the ADORA2A 
rs9608282-T on memory performance. 
 
rs9608282 is located upstream of ADORA2A (UCSC Genome Browser 
(GRCh37/hg19)) and is characterized by occurring during read-through 
transcription of two neighbor genes, SPECC1L (sperm antigen with calponin 
homology and coiled-coil domains 1-like) and ADORA2A (adenosine A2a 
receptor) on chromosome 22. This read-through transcription is a candidate for 
nonsense-mediated mRNA decay (NMD), which leads to no protein production. 
The inhibition of ADORA2A has been shown to enhance spatial memory and 
hippocampal plasticity through adult neurogenesis [304]. In the present study, 
rs9608282-T was associated with better memory and a larger hippocampal 
volume, suggesting that this variation may inhibit protein production of 
ADORA2A. Animal models or cell culture studies are needed to more completely 
characterize the function of this variation on brain structure and adult 
neurogenesis. 
 
Based on gene expression data from postmortem human brains, the A2A 
receptor is highly expressed in neurogenesis-related regions (CA1, CA2, CA3 
and dentate gyrus) of the hippocampus in the adult human brain. Since the 
dentate gyrus and CA3 regions are important for memory formation and pattern 
separation processes, as well as for learning new information, we believe the 
observed effect of the rs9608282-T variation may be protective for memory 
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performance by altering neurogenesis in these regions. In addition, the 
association of the rs9608282-T allele with hippocampal volume and 
neurogenesis-related sub-regions independent of diagnosis suggests that this 
effect might be a global rather than AD-specific phenomenon. Consistent with 
protective effect of this variant, decreased CSF total-tau protein levels were also 
observed in participants with at least one minor allele (T) of rs9608282. 
Interestingly, ADORA2A rs9608282-T and APOE ε4 exhibit an independent but 
opposite effect on hippocampal volume. In sum, we observed a significant 
protective effect of a variant (rs9608282) in the neurogenesis-related ADORA2A 
gene on brain structure and function, including increased hippocampal volume, 
better memory performance, and reduced CSF tau. This finding suggests that the 
adenosine A2a receptor warrants further investigation as a potential target for 
future therapeutics to treat neurodegenerative disease and cognitive decline. 
 
The eQTL analysis using the BRAINEAC brain tissue microarray-based gene 
expression database (http://www.braineac.org/) revealed that rs9608282 in 
ADORA2A is marginally associated with ADORA2A gene expression level in the 
hippocampus (p-value = 0.172). Individuals carrying minor allele rs9608282-T 
have decreased expression levels in the hippocampus, showing a potential 
protective effect same as our SNP-based association results with hippocampal 
volume and memory.  
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The limitation of the present report is that even though we used three 
independent publicly available databases to identify a curated gene list related to 
adult neurogenesis, it is possible that we may have missed other neurogenesis 
related genes not represented in these databases. The other limitation is that 
even though a few studies combined MRI-based hippocampal volume with 
immunochemistry to reveal that there is a significant hippocampal atrophy and 
the reduction of hippocampal neurogenesis in animal models, it is still not clear if 
hippocampal atrophy is related to adult neurogenesis in humans due to lack of 
data sources. Another limitation for this study is the lack of replication in the 
gene-based analysis. In the AddNeuroMed and IMAS, ADORA2A did not show a 
significant association with hippocampal volume but showed a trend. After 
combining three independent cohorts, the meta-analysis result was significant 
due to the increased detection power. In addition, future studies are needed to 
identify functional evidence to validate this SNP in ADORA2A. However, the 
present findings support that the ADORA2A gene plays a role in adult 
neurogenesis. AD is associated with hippocampal volume loss the observed 
effects indicates the potential importance of further investigation of this gene in 
independent cohorts. 
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III. Genome-wide association analysis of hippocampal volume identifies 
enrichment of neurogenesis-related pathways 
 
A. Introduction 
 
New neurons are generated throughout adulthood in two regions of the brain, the 
dentate gyrus of the hippocampus and olfactory bulb, and are incorporated into 
the hippocampal network. The pathways of adult neurogenesis include signaling 
transduction, the proliferation of neural progenitor cells, the fate determination of 
neural progenitor cell progenies, and the differentiation, migration, and 
maturation of adult neurons [4, 5]. In particular, multiple factors such as 
neurotrophic factors, transcription factors, and cell cycle regulators control neural 
stem cell (NSC) proliferation, maintenance in the adult neurogenic niche, and 
differentiation into mature neurons. The estimated annualized hippocampal 
atrophy rate is 1.41% for cognitively normal older adults and in adults, new 
neurons are added in each hippocampus daily via adult neurogenesis with an 
annual turnover of 1.75% and a modest decline during aging [3, 305]. A few 
studies focused on structural MRI and histological approaches to investigate 
newborn neurons and neural stem/progenitor cells in neurogenesis-related brain 
regions in mice, and it was found that neurogenesis is associated with increased 
hippocampal gray matter volume in mice [306]. Other studies combined MRI-
based hippocampal volume with immunochemistry to reveal that there is a 
significant hippocampal atrophy and the reduction of hippocampal neurogenesis 
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in adult rats who were exposed to oxygen deprivation during birth [307]. 
Molecular pathways and genes affect the induction of neurogenic niche and 
neural/progenitor cells turnover to newborn neurons for the formation of the 
hippocampal structure during hippocampal neurogenesis. 
 
To our knowledge, there is no study directly associating adult neurogenesis 
related pathways with hippocampal volume. In this study, we investigated 
whether neurogenesis-related pathways are enriched for hippocampal volume 
using a large-scale human neuroimaging genetics meta-analysis summary 
statistics (N~13,000). Although neurogenesis is an important contributor to the 
formation of the hippocampus in mice, it has not been studied fully in human 
brain whether adult neurogenesis is related to hippocampal volume yet. Genetic 
variation in neurogenesis-related genes in the human genome may have 
compensatory advantages or confer vulnerability to biological processes during 
adult neurogenesis but studies are needed to identify actual mechanism by which 
genetic variants affect neural stem cells differentiation, proliferation, and their 
maturation to new neurons in human brain.  
 
To better understand hippocampal volume and hippocampal atrophy are 
significantly associated with neurogenesis pathway, we performed a pathway 
enrichment analysis on a genome-wide association study (GWAS) from the 
Enhancing Neuro Imaging Genetics through Meta-Analysis (ENIGMA) 
consortium and Alzheimer’s Disease Neuroimaging Initiative data sets to identify 
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functional pathways associated with hippocampal volume and hippocampal 
atrophy. For further analysis, weighted gene co-expression network analysis 
(WGCNA) analysis (WGCNA) was performed using human brain gene 
expression data of cognitively normal individuals to identify clusters of highly 
correlated genes and investigate which each cluster is related to neurogenesis-
related pathways. 
 
B. Materials and Method 
 
Enhancing Neuro Imaging Genetics through Meta-Analysis (ENIGMA) 
 
The Enhancing NeuroImaging Genetics through Meta-Analysis Consortium 
(ENIGMA) was initiated in December 2009. The research group involved in 
neuroimaging and genetics worked together on a range of large-scale studies 
that integrated data from 70 institutions worldwide. The goal of ENIGMA was to 
merge neuroimaging data with genomic data and identify common variants that 
might affect the brain structure. The first project of ENIGMA was focused on 
identifying common variants associated with hippocampal volume or intracranial 
volume (ICV) [308]. The aim of ENIGMA2, follow-on study of ENIGMA1, was to 
perform genome-wide association analysis (GWAS) using the volumes of all 
subcortical structures. ENIGMA includes magnetic resonance images (MRI) of 
30,717 individuals from 50 cohorts [212].  GWAS was conducted using mean 
hippocampal volume as a phenotype controlling for age, gender, four 
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multidimensional scaling components, ICV, and diagnosis. The hippocampal 
volume was obtained from structural MRI data. MRI scans and genetic 
imputation were processed and examined by following standardized protocols 
freely available online (http://enigma.ini.usc.edu/protocols/imaging-protocols/). In 
this study, we used a meta-analysis GWAS summary statistics in the discovery 
sample of 13,163 subjects of European ancestry from the ENIGMA consortium 
(Hibar et al. 2015). 21% of the discovery participants have anxiety, Alzheimer’s 
disease, attention-deficit/hyperactivity disorder, bipolar disorder, epilepsy, major 
depressive disorder or schizophrenia. 9,339 out of 13,163 individuals are 
cognitively normal subjects.  
 
Alzheimer's Disease Neuroimaging Initiative (ADNI) 
 
ADNI was launched in 2003 by the National Institute on Aging, the National 
Institute of Biomedical Imaging and Bioengineering, the Food and Drug 
Administration (FDA), private pharmaceutical companies, and nonprofit 
organizations as a public-private partnership and recruited from 59 sites across 
the U.S. and Canada. ADNI includes over 1700 subjects consisting of cognitively 
normal older individuals (CN), significant memory concerns (SMC), mild cognitive 
impairment (MCI) and Alzheimer’s Disease (AD) aged 55-90 (http://www.adni-
info.org/). Subjects in ADNI have structural MRI scans and functional and 
psychological test data. The goal of ADNI is to identify whether serial MRI, positron 
emission tomography (PET), sensitive and specific other markers, and clinical and 
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neuropsychological assessments could be merged to measure the progression of 
mild cognitive impairment (MCI) and early AD. Participants for this study included 
367 CN, 94 SMC, 280 early MCI, 512 late MCI and 310 AD. Clinical and 
neuroimaging procedures and the other information about the ADNI cohort can be 
found at http://www.adni-info.org/. Table 6 shows selected demographic and 
clinical characteristics of these participants at the MRI scan time. 
 
Table 6. Demographic and clinical characteristics of ADNI participants 
 
 CN SMC EMCI LMCI AD 
N 367 94 280 512 310 
Age 
74.59 
(5.57) 
71.77 
(5.65) 
71.14  
(7.26) 
73.52  
(7.65) 
74.65  
(7.79) 
Gender 
(M/F) 
192/175 38/56 158/122 318/194 176/134 
Education 
16.32 
(2.68) 
16.81 
(2.57) 
16.08 (2.67) 
15.97  
(2.91) 
15.23  
(2.97) 
APOE 
( 
267/99 62/32 160/119 232/280 104/206 
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Genotyping data and quality control  
 
The genotyping data of ADNI participants were collected using the Illumina 
Human 610-Quad, HumanOmni Express, and HumanOmni 2.5M BeadChips. 
Standard quality control procedures of GWAS data for genetic markers and 
subjects were performed using PLINK v1.07 
(pngu.mgh.harvard.edu/∼purcell/plink). Sample and SNP quality control 
procedures were excluded with the criteria as SNP call rate < 95%, Hardy-
Weinberg equilibrium test p < 1 × 10−6, and frequency filtering (MAF ≥ 5%), 
participant call rate < 95%, sex check and identity check for related relatives 
[190, 285, 286, 309]. Non-Hispanic Caucasian participants were selected using 
HapMap 3 genotype data and the multidimensional scaling (MDS) analysis after 
performing standard quality control procedures for genetic markers and subjects. 
For imputation of un-genotyped SNPs, MaCH (Markov Chain Haplotyping) 
software based on the 1000 Genomes Project as a reference panel was used 
[271, 288]. 
 
Gene-set enrichment analysis 
 
Gene-set enrichment analysis of GWAS summary statistics was performed to 
identify pathways and functional gene sets with significant association to the 
hippocampal volume. All SNPs (n=6,571,356) and subjects with European 
ancestry were included in this study. Pathway annotations were downloaded 
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from Molecular Signatures Database version 5.0 
(http://www.broadinstitute.org/gsea/msigdb/index.jsp/). This annotation data 
comprised a collection of GO Ontology. GO gene sets comprise of publically 
available 1,454 pathways. 825 gene sets belong to GO biological process, 233 
gene sets belong to GO cellular components, and 396 gene sets belong to GO 
molecular function.  The GSA-SNP software [310] uses the p-value of each SNP 
from GWAS to test if a pathway-phenotype association is significantly different 
from all other pathway-phenotype associations. In GSA-SNP, ‘–log’ on each the 
kth best SNP-level p-value for each gene is taken. To avoid spurious 
conservative predictions, the second best SNP (k=2) was chosen for each gene 
as a default option instead of the best SNP. Each pathway (gene sets) was 
assessed by z-statistics for the identification of the enriched pathways with 
phenotype [311]. Analysis of these pathways was restricted to those containing 
between 10 and 200 genes. The FDR (Benjamini-Hochberg) method was applied 
for multiple comparison correction to the p-values generated by the enrichment 
algorithm [312]. We identified as enriched pathways with hippocampal volume if 
FDR-corrected p-value < 0.05 for each pathway.  
 
Genetic association analysis 
 
The KGG (Knowledge-based mining system for Genome-wide Genetic studies) 
software was used to perform a genome-wide gene-based analysis using GWAS 
p-values. KGG uses HYST (hybrid set-based test) to analyze the overall 
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association significance in a set of SNPs at the gene level. HYST is the 
combination of the gene-based association test using extended Simes procedure 
(GATES) and the scaled chi-square test [313, 314]. First, SNPs in each gene 
were divided into different LD blocks depending on pairwise LD coefficients r2 for 
all SNPs. Second, for each block, block-based p-value for association was 
calculated, and the key SNP was derived and marked. Next, the block-based p-
values were combined accounting for LD between the key SNPs using the scaled 
chi-square [315]. 
 
A targeted gene-based association analysis of enriched neurogenesis pathway-
related candidate genes for hippocampal volume was performed using a set-
based test in Plink v1.07 (http://pngu.mgh.harvard.edu/~purcell/plink/) [286]. The 
SNPs with p<0.05 for each gene were chosen. A mean test statistic for each 
SNP within a gene was computed to determine with which other SNPs it is in 
linkage disequilibrium (LD); i.e., if the correlation coefficient between them was 
r2>0.5. A quantitative trait analysis (QT) was then performed with each SNP. For 
each gene (set), the top independent SNPs (i.e., not in LD; maximum of 5) are 
selected if their p-values are less than 0.05. The SNP with the smallest p-value is 
selected first; subsequent independent SNPs are selected in order of decreasing 
statistical significance. From these subsets of SNPs, the statistic for each gene is 
calculated as the mean of these single SNP statistics. The analysis was 
performed using an additive model or in other words, the additive effect of the 
minor allele on the phenotypic mean was estimated [269, 286]. Covariates 
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included gender, age, years of education, and diagnosis status. An empirical p-
value (20,000 permutations) was reported for each gene for multiple comparison 
adjustment.  
 
Gene expression correlation analysis 
 
We used gene expression data for 32 cognitively normal samples generated 
using CA1 and CA3 regions of hippocampal tissues in NCBI’s Gene Expression 
Omnibus (GEO). The Illumina HumanHT-12 v3 Expression BeadChip (48,803 
probes) was used to measure expression of over 25,000 annotated genes. We 
processed data and removed the outliers as previously described [316]. We 
excluded probes if they present in three or fewer samples or if they do not 
correspond to any gene symbol annotations. Lastly we removed duplicate probes 
for a gene and just kept the highest expression level probe. After all data 
cleaning process, 15,037 genes remained. We performed weighted gene 
correlation network analysis (WGCNA) using processed expression data to 
identify clusters of highly correlated genes expressed in specific brain regions 
(CA1 and CA3) as modules. Pearson correlations between each gene pair were 
calculated. This matrix was transformed into signed adjacency matrix by using a 
power function. Then, topological overlap (TO) was calculated by using the 
components of this matrix. Thus, we measured the biological gene similarity 
depending on co-expression relationships of two genes with all other genes in 
the network. Genes were clustered hierarchically by the distance measure, 1-TO, 
 95 
and the dynamic tree algorithm determined initial module assignments [317]. 
Gene module membership between each gene and each module eigengene was 
calculated. We tested these modules for enrichment of neurogenesis-related 
pathways. 
 
C. Results 
 
Gene-set enrichment analysis, using  6,571,356 SNPs from the ENIGMA GWAS 
summary statistics, identified 44 significantly enriched biological pathways (FDR-
corrected p-value < 0.05) (Table 7) including 38 pathways related to 
neurogenesis processes. We classified neurogenesis related pathways as 
primary neurogenesis related pathways (N=19) and secondary (helper) 
neurogenesis related pathways (N=19) by using existing knowledge [318]  and 
literature mining (Figure 13).  
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Figure 13. Conceptual classification of 44 pathways enriched for the 
hippocampal volume. 
 
 
 
Nineteen primary pathways were related to cellular processes such as neuronal 
proliferation, differentiation and survival, cellular morphogenesis, axonogenesis, 
neuronal development, and signal transduction as well as cell-cell adhesion. 
Secondary neurogenesis pathways were consisted of enzyme activities related to 
neurogenesis, metabotropic receptor activity, lipoprotein binding and extracellular 
matrix. Six pathways were not related to any neurogenesis process such as 
oxidoreductase activity, phagocytosis, perinuclear region of cytoplasm and 
cornified envelope.  
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Table 7. Molecular Signatures Database (MSigDB) GO Ontology pathways 
enriched for hippocampal volume. 
 
Pathway 
(N=44) 
# of genes/set 
size 
Corrected 
p-value 
OXIDOREDUCTASE ACTIVITY ACTING  
ON SULFUR GROUP OF DONORS 
10/10 4.68x10-4 
NEURON DIFFERENTIATION 73/76 1.18 x 10-3 
CELL PROJECTION 105/108 1.18 x 10-3 
MICROVILLUS 11/11 1.48 x 10-3 
NEURITE DEVELOPMENT 51/53 3.12 x 10-3 
CELL RECOGNITION 18/19 3.12 x 10-3 
GENERATION OF NEURONS 80/83 3.12 x 10-3 
TRANSMEMBRANE RECEPTOR PROTEIN 
KINASE ACTIVITY 
50/51 3.12 x 10-3 
PROTEIN DOMAIN SPECIFIC BINDING 71/72 3.12 x 10-3 
NEURON DEVELOPMENT 59/61 3.24 x 10-3 
AXONOGENESIS 41/43 3.24 x 10-3 
CELLULAR MORPHOGENESIS DURING 
DIFFERENTIATION 
47/49 4.27 x 10-3 
NEUROGENESIS 90/93 5.65 x10-3 
TRANSMEMBRANE RECEPTOR PROTEIN 
TYROSINE KINASE ACTIVITY 
42/43 5.90 x 10-3 
VESICLE MEDIATED TRANSPORT 188/194 1.18 x10-2 
GLUTAMATE RECEPTOR ACTIVITY 20/20 1.18 x 10-2 
CYTOSKELETAL PROTEIN BINDING 153/159 1.18 x 10-2 
JNK CASCADE 45/47 1.19 x 10-2 
STRESS ACTIVATED PROTEIN KINASE 
SIGNALING PATHWAY 
47/49 1.30 x 10-2 
METABOTROPIC GLUTAMATEGABA B LIKE 
RECEPTOR ACTIVITY 
10/10 1.6 x 10-2 
PHAGOCYTOSIS 16/17 1.83 x 10-2 
REGULATION OF AXONOGENESIS 10/10 1.83 x 10-2 
REGULATION OF ANATOMICAL 
STRUCTURE MORPHOGENESIS 
24/25 1.83 x 10-2 
PERINUCLEAR REGION OF CYTOPLASM 51/54 1.88 x 10-2 
GLUTAMATE SIGNALING PATHWAY 16/17 2.13 x 10-2 
CORNIFIED ENVELOPE 12/13 2.32 x 10-2 
LIPOPROTEIN BINDING 18/18 2.46 x 10-2 
PDZ DOMAIN BINDING 14/14 2.54 x 10-2 
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PROTEIN TYROSINE KINASE ACTIVITY 62/63 2.7 x 10-2 
3 5 CYCLIC NUCLEOTIDE 
PHOSPHODIESTERASE ACTIVITY 
13/13 2.7 x 10-2 
NEGATIVE REGULATION OF CELL 
PROLIFERATION 
148/156 2.87 x 10-2 
PROTEIN OLIGOMERIZATION 35/40 2.87 x 10-2 
EXOPEPTIDASE ACTIVITY 29/32 2.87 x 10-2 
EXTRACELLULAR MATRIX 95/100 3.02 x 10-2 
CELL CELL ADHESION 83/86 3.02 x 10-2 
PROTEINACEOUS EXTRACELLULAR 
MATRIX 
93/98 3.02 x 10-2 
MAINTENANCE OF PROTEIN 
LOCALIZATION 
12/13 3.02 x 10-2 
MAINTENANCE OF CELLULAR PROTEIN 
LOCALIZATION 
11/11 3.02 x 10-2 
TRANSMEMBRANE RECEPTOR PROTEIN 
PHOSPHATASE ACTIVITY 
19/19 3.02 x 10-2 
CELL PROJECTION BIOGENESIS 23/25 3.04 x 10-2 
CYCLIC NUCLEOTIDE 
PHOSPHODIESTERASE ACTIVITY 
14/14 3.08 x 10-2 
CENTRAL NERVOUS SYSTEM 
DEVELOPMENT 
110/123 3.08 x 10-2 
PROTEIN TYROSINE PHOSPHATASE 
ACTIVITY 
52/53 3.08 x 10-2 
ACTIVE TRANSMEMBRANE 
TRANSPORTER ACTIVITY 
113/122 4.10 x 10-2 
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Since the inhibition of neurogenesis could be relevant to the hippocampal 
atrophy [319], we also examined if neurogenesis related pathways were enriched 
with hippocampal atrophy over two years with cognitively normal (CN) individuals 
with negative amyloid  pathology ([18F]Florbetapir PET scan or CSF amyloid  
measurement) (N=112) in ADNI. Seven pathways related to neurogenesis 
process were significantly enriched with hippocampal atrophy (FDR-corrected p-
value < 0.05) in cognitively normal adults. These pathways were related cellular 
differentiation, cellular morphogenesis during development, neurite development, 
axonogenesis, cell cell adhesion and neuron development (Table 8). 
 
Table 8. Molecular Signatures Database (MSigDB) GO Ontology pathways 
enriched with 2 years hippocampal atrophy. 
 
Pathway 
(N=7) 
# of 
genes/set 
size 
Corrected p-value 
CELLULAR MORPHOGENESIS 
DURING DIFFERENTIATION 
33/49 8.2 x 10-3 
REGULATION OF ANATOMICAL 
STRUCTURE MORPHOGENESIS 
18/25 8.2 x 10-3 
NEURITE DEVELOPMENT 34/53 8.2 x 10-3 
AXONOGENESIS 30/43 1.3 x 10-2 
CELL CELL ADHESION 54/86 1.3 x 10-2 
NEURON DEVELOPMENT 40/61 5.0 x 10-2 
TRANSMEMBRANE RECEPTOR 
PROTEIN PHOSPHATASE ACTIVITY 
15/19 5.0 x 10-2 
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Furthermore, we performed a targeted gene-based association analysis of 
hippocampal neurogenesis-pathway associated candidate genes using the 
ENIGMA GWAS summary [313]. The gene-based analysis showed that 4 genes 
(MSRB3, TESC, DPP4, ACVR1) were significantly associated with hippocampal 
volume (corrected p-value < 0.05, Table 9).  
 
Table 9. Gene-based association results (p-value) of four significant genes 
for hippocampal volume using common variants (MAF ≥ 0.05), where p-
values were calculated using GATES software. 

Gene Corrected p-value 
MSRB3 3.4 x 10-6 
TESC 1.3 x 10-2 
DPP4 3.7 x 10-2 
ACVR1 4.8 x 10-2 
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Since hippocampal volume is correlated with memory performance, we 
performed a gene based association analysis of these four genes (with 682 
SNPs) with composite memory scores. The gene-based association analysis 
showed that TESC gene is significantly associated with composite memory score 
after Bonferroni correction in ADNI dataset (p-value = 5.7x10-3, Table 10).  
 
Table 10. Gene-based association results (p-values) of four genes for 
composite memory scores using common variants (MAF ≥ 0.05), where 
empirical p-values were calculated using 20,000 permutations in PLINK. 
 
 
Gene 
ADNI 
(N=1,563) 
p-value Significant independent 
SNP 
MSRB3 0.26 rs7294862|rs6581626 
TESC 5.7 x 10-3 rs117692586|rs12302906 
DPP4 0.26 rs35635667|rs3788979 
ACVR1 1 N/A 
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One SNP (rs117692586) upstream of TESC was most associated with composite 
memory score and Rey Auditory Verbal Learning Test (RAVLT) scores (p-value = 
4.3x10-4 and 6.8x10-4, respectively; Table 11). rs117692586-T is associated with 
poorer memory performance (Figure 14). 
 
Table 11. SNP-based analysis results for memory scores in ADNI. 
 
rs117692586 (TESC) 
ADNI 
(N=1,563) 
β p-value 
Memory Composite 
Score 
 -0.1487 4.3 x 10-4 
RAVLT-Total  -2.486  6.8 x 10-4 
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Figure 14. TESC (rs117692586-T) is significantly associated with poorer 
composite memory score: Presence of at least one copy of the minor allele (T) 
of rs117692586 was significantly associated with poorer memory score  
(p-value ≤ 0.001) 
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Finally, we used gene expression data from Gene Expression Omnibus (GEO) to 
evaluate if the neurogenesis pathways were enriched for CA1 and CA3 regions 
of the hippocampus in normal brain tissues. A weighted gene correlation network 
analysis (WGCNA) yielded 20 modules of co-expressed genes in these data. 
These 20 modules were tested for enrichment of neurogenesis pathways. Six 
modules were found to be significantly enriched with neurogenesis pathways 
after correcting for multiple testing. The six significantly enriched modules are all 
related to neurogenesis pathways such as neuronal proliferation and 
differentiation as well as cellular process (Table 12).   
 
Table 12: GSEA pathway analysis result showed that six pathways are 
related to neurogenesis after Bonferroni correction. 
 
Neurogenesis Pathway Corrected p-value 
Module 1 5.2 x 10-84 
Module 2 1.0 x 10-21 
Module 3 3.8 x 10-17 
Module 4 4.4 x 10-11 
Module 5 3.0 x 10-7 
Module 6 7.6 x 10-4 
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D. Discussion 
 
Using a large-scale genome-wide association study (GWAS) summary statistics 
associated with hippocampal volume in the discovery sample of 13,163 subjects 
of European ancestry from the ENIGMA consortium, we performed a genome-
wide gene-set enrichment analysis and identified 44 GO Ontology pathways with 
enrichment for hippocampal volume. These enriched pathways showed that 
hippocampal volume is related to neurogenesis and cellular processes including 
neuronal cell proliferation, differentiation and maturation as well as cell adhesion. 
In addition, the evidence for the enrichment of neurogenesis related pathways in 
the hippocampus was obtained by performing WGCNA on gene expression data 
from 32 healthy hippocampal brain regions (CA1 and CA2).  
 
At a cellular level, the enriched pathways showed significant relationships 
between neurogenesis and hippocampal volume/atrophy. Since several studies 
showed the neurogenesis occurs in the dentate gyrus of the hippocampus [318], 
it is not surprising hippocampal volume is significantly related to neurogenesis-
related pathways. In particular, we observed significant enrichment of pathways 
related to cell proliferation, neuron differentiation, neuron generation, neurite 
development, neuronal development, cell recognition, neurogenesis and 
axonogenesis. The neural progenitor cells in the subgranular zone of the 
hippocampus differentiate and incorporate into neural network circuitry as mature 
neurons in the adult human brain [3]. In addition these newborn neurons 
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enhance the formation of the hippocampus during neurogenesis and many genes 
involve these processes [12, 258]. Moreover, our pathway enrichment analysis 
for hippocampal volume revealed that hippocampal volume is significantly related 
to signal transductions such as glutamate signaling, protein kinase signaling and 
JNK cascade. We identified five neurogenesis related pathways in our previous 
review paper and signal transduction pathways were one of the important 
pathways in adult neurogenesis process [318]. During adult neurogenesis, 
functional granule cells in the dentate gyrus of the adult hippocampus release 
glutamate, project to target cells in CA3 region, and receive glutamatergic and γ-
aminobutyric acid GABAergic inputs to control their spiking activity in neuronal 
network which supports the formation of the memory and learning [43, 320]. 
Phosphoinositide 3-kinase (PI3K)/protein kinase pathways enhance neuronal 
differentiation and inhibit the apoptosis of the progenitor cells [50, 321]. In 
addition, studies showed that JNK1 in JNK cascade plays a role in neuronal 
differentiation, neuronal and axonal maturation [322-324]. Also, it has been 
showed that absence of JNK1 enhances hippocampal neurogenesis and reduces 
anxiety-related phenotype in mice model [322].  
 
Pathways related to enzyme activities such as protein tyrosine kinase, protein 
tyrosine phosphatase and 3’5’ cyclic nucleotide phosphodiesterase were 
enriched for hippocampal volume. Studies showed that three subfamilies, Tyro3, 
Axl and Mertk (TAM), of receptor protein tyrosine kinases plays a crucial role in 
adult neurogenesis. TAM receptors have different impacts on proliferation and 
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differentiation of neural stem cells to immature neurons by controlling 
overproduction of pro-inflammatory cytokines [325]. Protein tyrosine phosphatase 
controls the differentiation of the neural stem cells during neurogenesis [326].  
 
Our enrichment analysis results suggest the impact of neurogenesis-related 
genetic variation on hippocampal structure. We examined genes that were 
highly-represented across the neurogenesis-related pathways and showed that 
two genes, tescalcin (TESC) and activin receptor 1 (ACVR1), were significantly 
related to hippocampal volume. In addition, in ADNI, TESC was significantly 
associated with memory performance. Previous structural imaging studies 
showed the TESC-regulating polymorphism is significantly associated with 
hippocampal volume and hippocampal gray matter structure [308, 327]. TESC 
cooperates with the plasma membrane Na(+)/H(+) exchanger NHE1 which 
catalyzes electroneutral influx of extracellular Na(+) and efflux of intracellular 
H(+) and establishes intracellular pH level as well as cellular hemostasis [328, 
329]. TESC was expressed in the various tissues such as heart and brain and 
plays an important role during embryonic development [329]. TESC plays a 
crucial role in controlling cell proliferation and differentiation for the formation of 
the hippocampal structure during brain development [327]. In addition,  ACVR1, 
member of a protein family called as bone morphogenetic protein (BMP) type I 
receptors, regulates dentate gyrus stem cells during neurogenesis [330]. In 
addition, gene co-expression results showed that TESC and ACVR1 were co-
expressed together in the neurogenesis related module.  
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There are some limitations in the present report: 1) in this study we used GO 
Ontology pathways from MSigDB.  For pathway enrichment analysis design, 
there is no gold standard. There are many tools and strategies for pathway 
enrichment analysis and alternate databases and algorithms for pathway 
enrichment analysis can affect the analytic results [192, 331]; 2) another 
limitation is the lack of replication in the gene-set enrichment analysis. We could 
not find any large data sets with imaging and genetics data to replicate our 
results. Further study would be warranted using independent large data sets to 
replicate our pathway enrichment.   
 
In summary, our results provide the evidence that neurogenesis-related 
pathways are enriched for hippocampal volume, suggesting that hippocampal 
volume may serve as a potential phenotype for the investigation of neurogenesis. 
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IV. Genome-wide association analysis of AD pathology-related 
phenotypes identifies enrichment of neurogenesis-related pathways 
 
A. Introduction: 
 
Alzheimer’s disease (AD) is the most common form of dementia and 
characterized by two hallmarks, amyloid-β accumulation and neurofibrillary 
tangles. Tau, a microtubule associated protein (MAP), promotes microtubules 
assembly and stabilization in mature neuron [332]. Tau plays a crucial role in 
brain development. Absence of tau inhibits neuronal migration, normal 
morphology of radial cells, and synaptic maturation of newborn hippocampal 
granule neurons [333, 334] . The pathological overexpression of tau protein 
causes tau-related neurological diseases known as tauopathies [335]. AD is the 
most common form of tauopathy and is associated with hyperphosphorylation of 
tau protein leading to the formation of neurofibrillary tangles in the brain [333]. 
The protein tau is the main component of neurofibrillary tangles (NFT) leading to 
neuronal death in the hippocampus of AD patients. In contrast, tau plays a crucial 
role for neurogenesis and synaptic maturation of newborn hippocampal granule 
neurons, and the absence of tau can result in retarded neurogenesis and 
neuronal differentiation [334]. Total tau (t-tau), and tau phosphorylated at the 
threonine 181 (p-tau181p), measured in cerebrospinal fluid (CSF) samples are 
used as diagnostic biomarkers for AD patients.  
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In addition to tau pathology in AD, amyloid-β deposition in the brain is the other 
crucial hallmark for AD. Amyloid-β 1-42 peptide (Aβ1-42) in CSF is an 
established diagnostic biomarker for AD [268]. Amyloid precursor protein (APP) 
plays a significant role for new born neuron survival and maturation. Even though 
Alevel decreases in the hAPP mouse model, overexpression of the human APP 
leads to impairment of the adult neurogenesis due to the reduction of the neural 
stem/precursor cells [336]. However, Aaccumulation in the brain impairs 
neurogenesis in the subgranular layer of the dentate gyrus [337]. On the other 
hand, since impaired presynaptic GABAergic input leads to decrease in the 
maturation of the newborn neurons and GABAergic signaling normalizes 
neurogenesis in APOE4 knock-in mice, the imbalance between GABAergic and 
glutamatergic neurotransmission has a negative effect on neurogenesis [338, 
339].  
 
While amyloid-β accumulation has a negative effect on adult neurogenesis, 
amyloid-β precursor protein (APP) plays an important role in neuronal survival 
and maturation. Interestingly, neurogenesis occurs in the dentate gyrus of the 
hippocampus during adulthood that is also a prominent site of NFT accumulation. 
To test whether tau tangles and amyloid-β deposition are significantly associated 
with neurogenesis-related pathways, we performed gene-set enrichment analysis 
on a genome-wide association study (GWAS) from the Alzheimer’s Disease 
Neuroimaging Initiative (ADNI), which uniquely has GWAS data sets on the same 
participants as well as multi-modal structural and functional neuroimaging (MRI, 
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PET) data as well as CSF data. We used [18F]Flortaucipir PET scans for the 
measurement of the tau pathology and [18F]Florbetapir PET scans for the global 
cortical amyloid-β deposition as quantitative traits to investigate whether adult 
hippocampal neurogenesis-related genes and pathways are significantly 
associated with AD pathology-related endophenotypes. In addition, set –based 
pathway enrichment analysis was performed from three CSF biomarkers (Aβ1-
42, t-tau, and p-tau181p) in ADNI.   
 
B. Materials and Method 
 
Alzheimer's Disease Neuroimaging Initiative (ADNI) 
 
Data used in this study were obtained from the ADNI database 
(adni.loni.usc.edu). ADNI was launched in 2003 by a public-private partnership 
and initiated by Michael W. Weiner. Participants were recruited from more than 
50 sites across the United States and Canada. ADNI participants consist of 
cognitively normal older individuals (CN), significant memory concerns (SMC), 
mild cognitive impairment (MCI) and AD aged 55-90 (http://www.adni-info.org/). 
ADNI dataset include structural MRI and PET scans, longitudinal CSF markers, 
and performance on neuropsychological and clinical assessments. In addition, All 
ADNI samples have APOE and genome-wide genotyping data.In this study, we 
used Amyloid-β 1-42 peptide (Aβ1-42), total tau, and tau phosphorylated at the 
threonine 181 (p-tau181p) measured in CSF samples and [18F]AV-1451 
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Flortaucipir PET. 1,154 (AD = 220, MCI = 597, SMC = 84, CN = 253) non-
Hispanic Caucasian participants have CSF total tau and p-tau levels. 975 of the 
participants (AD = 213, MCI = 517, SMC = 60, CN = 185) have CSF amyloid beta 
level. 800 participants (AD = 131, MCI = 422, SMC = 90, CN = 157) have [18F] 
Florbetapir PET scans and 99 of the ADNI participants (AD = 10, MCI = 44, SMC 
= 11, CN = 34) have [18F]AV-1451 Flortaucipir PET scans. 
 
CSF measurements and quality control 
 
All data were downloaded from the LONI website as “UPENN CSF Biomarkers 
Elecsys”. The complete descriptions of the collection and process protocols are 
provided in the ADNI procedural manual at www.adni-info.org.  
 
[18F]Florbetapir and [18F]Flortaucipir PET scans 
 
18F-labeled Aβ tracer florbetapir was used for PET imaging from the ADNIGO/2 
participants. First, 370 MBq florbetapir was injected to participants. After 50 
minutes, cranial PET scans were initiated. Florbetapir PET scans and processing 
were provided as online (http://adni.loni.usc.edu/wp-
content/uploads/2010/05/ADNI2_PET_Tech_Manual_0142011.pdf; 
http://adni.loni.usc.edu/methods/pet-analysis/pre-processing/). Briefly, all of the 
florbetapir scans were examined for quality control. Images were averaged and 
aligned into a standard 160 × 160 × 96 voxel image grid with 1.5 mm cubic 
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voxels, and smoothed to a uniform isotropic resolution of 8 mm full width at half 
maximum and normalized to an atlas-based cerebellar reference region. These 
scans were downloaded ADNI website (http://adni.loni.ucla.edu/) for 802 
participants. In the Statistical Parametric Mapping 8 (SPM8) software 
(http://www.fil.ion.ucl.ac.uk/spm/software/spm8/), MarsBaR toolbox were used to 
extract mean regional SUVR values for the frontal, parietal, temporal, limbic, and 
occipital lobes that represent Aβ accumulation in the global cortical area. We 
used a global cortical measurement as a quantitative phenotype for GWAS. After 
quality control of data, 800 individuals were used for analysis.  
 
Pre-processed 80-100 minute [18F]Flortaucipir scans were downloaded from 
LONI and processed using standard techniques. Prior to download, 
[18F]Flortaucipir images were averaged, aligned to a standard space, re-sampled 
to a standard image and voxel size, smoothed to a uniform resolution and 
intensity normalized as previously described [340]. After downloading, scans 
were co-registered to the closest time point structural MRI, normalized to 
Montreal Neurologic Institute (MNI) space, and intensity normalized to mean 
cerebellar crus uptake to create SUVR images. Regional [18F]Flortaucipir from 
the global cortex was extracted from subject-specific regions of interest 
generated from Freesurfer version 5.1. After quality control of the data, 99 
individuals were used for analysis. 
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Genotyping Data and Quality Control  
 
Genomic DNA was extracted using the QIAamp DNA Blood Maxi Kit (Qiagen, 
Inc., Valencia, CA) following the manufacturer's protocol using 7 mL of blood in 
EDTA-containing Vacutainer tubes from all participants. 50 ng of genomic DNA 
from each sample was examined for quality control on a 1% Tris-acetate-EDTA 
agarose gel to check for degradation. Degraded DNA samples were excluded 
from further analysis [268]. ADNI samples were genotyped according to 
manufacturer’s protocol (Illumina, Inc., San Diego, CA) using the Human610-
Quad BeadChip (for subjects initially enrolled during ADNI-1) or the Human 
OmniExpress BeadChip (for subjects initially enrolled in ADNI-GO or ADNI-2). In 
addition, two SNPs that characterize APOE ε2/ε3/ε4 allele status (rs429358 and 
rs7412) were genotyped using DNA extracted by Cogenics from a 3 mL aliquot of 
EDTA blood [341]. These SNPs were genotyped by PCR amplification using 
HhaI restriction enzyme digestion and Metaphor Gel [342].  
 
SNP quality control procedures of GWAS data such as SNP call rate < 95%, 
Hardy-Weinberg equilibrium test p < 1 × 10−6, and frequency filtering (MAF ≥ 5%) 
were performed using PLINK (http://pngu.mgh.harvard.edu/~purcell/plink/), 
version 1.07 [190, 285-287]. For sample quality procedures, due to the limitation 
of the population stratification, only non-Hispanic Caucasian participants were 
selected for this analysis by genetic clustering with CEU (Utah residents with 
Northern and Western European ancestry from the CEPH collection) and TSI 
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(Tuscans in Italy) populations using HapMap 3 genotype data and 
multidimensional scaling (MDS) analysis after performing standard quality control 
(QC) procedures for genetic markers and participants [190, 343].  
 
Prior to imputation, all genotyped markers were verified using NCBI build 37 
coordinates reference panel genome. Monomorphic variants from reference 
genome were excluded. Imputation of un-genotyped SNPs was performed using 
MaCH (Markov Chain Haplotyping) and minimac software based on the 1000 
Genomes Project as a reference panel [288]. Following imputation, SNPs with 
less correlation (r2 < 0.5) between imputed and assayed genotypes were 
removed [308]. The independently-imputed data sets were then merged to 
generate a common set of more than 10 million SNPs for the full ADNI sample. 
Following quality control (SNP call rate < 95%, Hardy-Weinberg p < 1 × 10−6) and 
frequency filtering (MAF < 5%), 6,112,217 SNPs were included in the GWAS.  
 
Genome-wide association analysis 
 
To generate input data for gene-set enrichment analysis, GWAS for AD-related 
phenotypes such as CSF biomarkers (Aβ1-42, t-tau and p-tau181) and PET 
measurements (tau and amyloid beta deposition) was performed using additive 
model with a linear association analysis for quantitative traits in Plink. Age, sex 
and diagnosis were used as covariates. In addition, APOE ε4 allele status 
(presence vs. absence) was also used as a covariate in the GWAS to account for 
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the largest known genetic effect on AD-related phenotypes. A p-value for each 
SNP was generated from GWAS using Plink.  
 
Gene-set enrichment analysis 
 
Pathway annotations were downloaded from Molecular Signatures Database 
version 5.0 (http://www.broadinstitute.org/gsea/msigdb/index.jsp/). This 
annotation data comprised a collection of GO Ontology. GO gene sets comprise 
of publically available 1,454 pathways. 825 gene sets belong to GO biological 
process, 233 gene sets belong to GO cellular components, 396 gene sets belong 
to GO molecular function.  The GSA-SNP software [310] was used for a gene-set 
enrichment analysis. GSA-SNP is a JAVA-based stand-alone software and uses 
the p-values of each marker from genome-wide association results to test if a 
pathway-phenotype association is significantly different from all other pathway-
phenotype association. In GSA-SNP, ‘–log’ on the kth best SNP-level p-value for 
each gene is taken. According to author suggestion toavoid spurious 
conservative predictions, the second best SNP (k=2) was chosen for each gene 
as a default option instead of the best SNP. Each pathway (gene sets) was 
assessed by z-statistics for the identification of the enriched pathways with 
phenotype [311]. Analysis of these pathways was restricted to those containing 
between 10 and 200 genes. The FDR (Benjamini-Hochberg) method was applied 
for multiple comparison correction to the p-values generated by the enrichment 
algorithm [312]. We identified pathways as significantly enriched if FDR-corrected 
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p-value < 0.05 for each pathway. 
 
Gene-based association analysis 
 
The KGG (Knowledge-based mining system for Genome-wide Genetic studies) 
software was used to perform a genome-wide gene-based analysis using GWAS 
p-values for AD pathology-related endophenotypes such as CSF biomarkers 
(Aβ1-42, t-tau and p-tau181) and tau and amyloid beta deposition measured from 
PET scans. Hybrid set-based test, the combination of the set of genome wide 
association signals from all SNPs was used for gene-based association analysis 
[313, 314]. KGG procedures can be found in chapter III in detail.  
 
C. Results 
 
GWAS was performed from five different AD-related phenotypes: CSF 
biomarkers (Aβ1-42, t-tau and p-tau181) and tau and amyloid beta deposition 
measured from PET scans. The p-values from the GWAS results were used as 
input for gene-set enrichment pathway analysis. We identified 47 pathways 
related to CSF t-tau levels, 54 pathways related to CSF p-tau levels and 43 
pathways related to tau PET. 45 of the pathways were common in t-tau and p-tau 
levels in CSF. After we examined the enriched pathways deeply for tau 
pathology, we discovered that all of the 45 pathways are related to neurogenesis 
process, generation of neurons, axonogenesis, cell-cell adhesion, glutamate 
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transmission, signal transduction, cellular process and synaptic transduction 
(Table 13). 12 out of these 45 pathways were also common in enriched pathways 
for tau accumulation in the global cortical region in the brain (Table 13). We 
classified pathways associated with CSF t-tau and p-tau levels as primary 
neurogenesis pathways (N=25) and secondary (helper) pathways (N=20).  
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Table 13: Molecular Signatures Database (MSigDB) GO Ontology pathways 
enriched for CSF total tau and p-tau levels and tau PET. 
 
Pathway 
N=45 
Corrected 
p-value 
(CSF t-tau) 
Corrected 
p-value 
(CSF p-tau) 
Corrected  
p-value  
(tau PET) 
CDC42 PROTEIN SIGNAL 
TRANSDUCTION 
 < 10-11 < 10-12 N/A 
REGULATION  
OF AXONOGENESIS 
2.27 x 10-11 < 10-12 2.4 x 10-2 
LEARNING AND OR MEMORY 2.14 x 10-8 < 10-12 N/A 
REGULATION OF SYNAPSE 
STRUCTURE AND ACTIVITY 
2.41 x 10-8 < 10-12 N/A 
REGULATION  
OF NEUROGENESIS 
1.06 x 10-7 1.79 x 10-12 1.5 x 10-2 
PROTEIN TETRAMERIZATION 1.59 x 10-6 1.39 x 10-10 N/A 
HOMOPHILIC CELL ADHESION 1.59 x 10-6 5.19 x 10-10 N/A 
LIPID HOMEOSTASIS 3.73 x 10-6 5.90 x 10-9 N/A 
REGULATION OF ANATOMICAL 
STRUCTURE 
MORPHOGENESIS 
4.03 x 10-6 4.46 x 10-10 N/A 
NEURON DIFFERENTIATION 8.31 x 10-6 1.47 x 10-7 1.6 x 10-3 
NEURON DEVELOPMENT 8.31 x 10-6 5.40 x 10-8 1.2 x 10-2 
NEURITE DEVELOPMENT 8.31 x 10-6 4.86 x 10-8 4.5 x 10-3 
SYNAPTIC TRANSMISSION 2.73 x 10-5 4.79 x 10-7 N/A 
PROTEIN DIMERIZATION 
ACTIVITY 
2.73 x 10-5 6.29 x 10-9 N/A 
CELL CELL ADHESION 2.83 x 10-5 2.52 x 10-7 N/A 
CELLULAR MORPHOGENESIS 
DURING DIFFERENTIATION 
2.83 x 10-5 7.75 x 10-7 6.6x10-3 
RHO PROTEIN SIGNAL 
TRANSDUCTION 
2.93 x 10-5 3.55 x 10-7 N/A 
GENERATION OF NEURONS 3.14 x 10-5 1.41 x 10-6 5.0 x 10-3 
AXONOGENESIS 6.17 x 10-5 1.03 x 10-6 1.16 x 10-2 
PROTEIN OLIGOMERIZATION 1.59 x 10-4 6.72 x 10-6 N/A 
PROTEIN HOMODIMERIZATION 
ACTIVITY 
1.84 x 10-4 3.55 x 10-7 N/A 
NEUROGENESIS 1.85 x 10-4 2.02 x 10-5 4.5 x 10-3 
TRANSMISSION OF NERVE 
IMPULSE 
2.15 x 10-4 1.03 x 10-5 N/A 
RAS PROTEIN SIGNAL 
TRANSDUCTION 
1.39 x 10-3 1.88 x 10-4 N/A 
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PROTEIN 
HETERODIMERIZATION 
ACTIVITY 
1.40 x 10-3 9.43 x 10-6 N/A 
LIPID TRANSPORT 3.05 x 10-3 7.59 x 10-5 N/A 
GLUTAMATE RECEPTOR 
ACTIVITY 
3.55 x 10-3 2.74 x 10-3 N/A 
TRANSMEMBRANE RECEPTOR 
PROTEIN PHOSPHATASE 
ACTIVITY 
3.76 x 10-3 1.05 x 10-2 5.9 x 10-4 
SMALL GTPASE MEDIATED 
SIGNAL TRANSDUCTION 
4.07 x 10-3 5.18 x 10-4 N/A 
POSITIVE REGULATION  
OF TRANSCRIPTION 
5.31 x 10-3 3.40 x 10-2 N/A 
CYTOSKELETAL PROTEIN 
BINDING 
5.31 x 10-3 2.60 x 10-4 N/A 
POSITIVE REGULATION  
OF TRANSCRIPTION  
DNA DEPENDENT 
8.63 x 10-3 3.40 x 10-2 N/A 
POSITIVE REGULATION OF 
RNA METABOLIC PROCESS 
1.16 x 10-2 4.28 x 10-2 N/A 
POSITIVE REGULATION OF 
NUCLEOBASE NUCLEOSIDE 
NUCLEOTIDE AND NUCLEIC 
ACID METABOLIC PROCESS 
1.23 x 10-2 4.75 x 10-2 N/A 
TRANSMEMBRANE RECEPTOR 
PROTEIN TYROSINE KINASE 
ACTIVITY 
1.52 x 10-2 1.09 x 10-2 4.6 x 10-4 
PHOSPHOLIPID BINDING 1.88 x 10-2 1.94 x 10-4 N/A 
3 5 CYCLIC NUCLEOTIDE 
PHOSPHODIESTERASE 
ACTIVITY 
2.31 x 10-2 6.94 x 10-3 9.97 x 10-3 
LIPID TRANSPORTER ACTIVITY 2.31 x 10-2 4.60 x 10-3 N/A 
REGULATION OF RAS GTPASE 
ACTIVITY 
2.64 x 10-2 1.58 x 10-2 N/A 
NUCLEAR MATRIX 3.38 x 10-2 1.58 x 10-2 N/A 
REGULATION OF CELLULAR 
COMPONENT ORGANIZATION 
AND BIOGENESIS 
3.80 x 10-2 8.66 x 10-3 N/A 
DEPHOSPHORYLATION 3.90 x 10-2 4.30 x 10-2 N/A 
CENTRAL NERVOUS SYSTEM 
DEVELOPMENT 
4.02 x 10-2 4.28 x 10-2 N/A 
PROTEIN AMINO ACID 
DEPHOSPHORYLATION 
4.0 x 10-2 3.40 x 10-2 N/A 
PROTEIN TYROSINE 
PHOSPHATASE ACTIVITY 
4.0 x 10-2 4.75 x 10-2 N/A 
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Primary pathways are related to cell differentiation, proliferation, survival, cellular 
morphogenesis, synaptic transduction, axonogenesis, neuronal development, 
regulation of cellular organization, glutamate signaling, cell-cell adhesion, lipid 
homeostasis, and memory and learning. Secondary neurogenesis pathways are 
related to enzyme activity, protein dimerization, phospholipid binding, lipoprotein 
binding, and extracellular matrix.  
 
Next, 1,251 genes highly-represented across 45 enriched pathways common 
with CSF t-tau and p-tau levels were identified. Gene-based association analysis 
using KGG showed that three genes (APOE, PVRL2 and APOC4) are 
significantly associated with CSF t-tau and p-tau levels after multiple comparison 
adjustments (Table 14).  
 
Table 14.  Gene-based association analysis of genes linked to the enriched 
neurogenesis-related pathways. Three genes are associated with CSF t-tau 
levels and p-tau levels after multiple comparison adjustments. 
 
 
Gene 
N=1,251 
Corrected p-value 
(CSF t-tau) 
Corrected p-value 
(CSF p-tau) 
APOE 1.16 x 10-10 5.27 x 10-15 
PVRL2 4.19 x 10-7 2.51 x 10-10 
APOC4 3.50 x 10-3 3.92 x 10-5 
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When we used APOE ε4 allele status as a covariate, only two pathways were 
related to CSF t-tau levels and eleven pathways were related to CSF p-tau in the 
gene-set enrichment analysis. After adjustment of APOE ε4 allele status, the 
most of the neurogenesis pathways were not enriched for CSF t-tau levels.    
We performed pathway enrichment analysis using GWAS results from CSF Aβ1-
42 and amyloid beta deposition (measured from PET) in the cortical regions in the 
brain. Gene-set enrichment analysis results showed that 40 pathways were 
enriched with CSF Aβ1-42, while 54 pathways enriched for amyloid  deposition. 
36 common pathways enriched for CSF Aβ1-42 and [18F]Florbetapir PET 
measurement (Table 15). 
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Table 15. Molecular Signatures Database (MSigDB) GO Ontology pathways 
enriched for amyloid-β in CSF and Amyloid PET. 
 
Pathway 
N=36 
Corrected  
p-value  
(CSF Aβ) 
Corrected  
p-value 
(Amyloid PET) 
REGULATION OF AXONOGENESIS < x 10-13 < x 10-13 
REGULATION OF SYNAPSE 
STRUCTURE AND ACTIVITY 
< x 10-13 < x 10-13 
CDC42 PROTEIN SIGNAL 
TRANSDUCTION 
< x 10-13 < x 10-13 
REGULATION OF NEUROGENESIS < x 10-13 < x10-13 
LEARNING AND OR MEMORY < x 10-13 < x 10-13 
PROTEIN TETRAMERIZATION < x 10-13 < x 10-13 
HOMOPHILIC CELL ADHESION < x 10-13 < x 10-13 
LIPID HOMEOSTASIS < x 10-13 < x 10-13 
REGULATION OF ANATOMICAL 
STRUCTURE MORPHOGENESIS 
< x 10-13 < x 10-13 
AXONOGENESIS < x 10-13 1.84 x 10-10 
NEURITE DEVELOPMENT 1.52 x 10-13 3.08 x 10-8 
CELLULAR MORPHOGENESIS 
DURING DIFFERENTIATION 
3.95 x 10-13 3.52 x 10-9 
NEURON DIFFERENTIATION 1.89 x 10-12 6.88 x 10-7 
NEURON DEVELOPMENT 2.07 x 10-12 8.41 x 10-7 
PROTEIN HOMODIMERIZATION 
ACTIVITY 
6.33 x 10-12 3.21 x 10-12 
NEUROGENESIS 1.68 x 10-11 8.13 x 10-5 
GENERATION OF NEURONS 1.80 x 10-12 1.94 x 10-6 
PROTEIN OLIGOMERIZATION 5.84 x 10-12 1.36 x 10-12 
LIPID TRANSPORT 5.84 x 10-12 3.46 x 10-11 
PROTEIN DIMERIZATION ACTIVITY 2.53 x 10-10 1.28 x 10-10 
RHO PROTEIN SIGNAL 
TRANSDUCTION 
4.25 x 10-10 6.34 x 10-10 
PHOSPHOLIPID BINDING 5.81 x 10-9 9.48 x 10-13 
RAS PROTEIN SIGNAL 
TRANSDUCTION 
1.28 x 10-8 6.85 x 10-5 
CELL CELL ADHESION 1.88 x 10-7 3.22 x 10-10 
SYNAPTIC TRANSMISSION 2.66 x 10-7 6.19 x 10-6 
PROTEIN HETERODIMERIZATION 
ACTIVITY 
8.68 x 10-7 4.53 x 10-6 
TRANSMISSION OF NERVE IMPULSE 1.15 x 10-6 3.66 x 10-6 
CYTOSKELETAL PROTEIN BINDING 5.89 x 10-6 3.10 x 10-3 
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SMALL GTPASE MEDIATED SIGNAL 
TRANSDUCTION 
1.06 x 10-5 1.67 x 10-4 
TRANSMEMBRANE RECEPTOR 
PROTEIN PHOSPHATASE ACTIVITY 
5.43 x 10-5 2.47 x 10-4 
PROTEIN COMPLEX ASSEMBLY 3.37 x 10-4 3.23 x 10-4 
BEHAVIOR 3.57 x 10-4 3.00 x 10-3 
LIPID BINDING 3.92 x 10-4 1.11 x 10-5 
REGULATION OF CELLULAR 
COMPONENT ORGANIZATION AND 
BIOGENESIS 
1X10-3 3.32 x 10-2 
CYTOSKELETON ORGANIZATION AND 
BIOGENESIS 
1.7 x 10-2 2.51 x 10-2 
TRANSMEMBRANE RECEPTOR 
PROTEIN TYROSINE KINASE 
SIGNALING PATHWAY 
3.9 x 10-2 4.49 x 10-3 
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All the pathways were related to neurogenesis process, cellular process, 
neuronal development, neuronal differentiation, cell-cell adhesion, ras signaling 
pathway, rho signaling pathway and axonogenesis. Interestingly, all these 36 
common pathways are primarily associated with neurogenesis processes or 
helpers playing a role in cellular processing during neurogenesis.1,272 genes 
were identified from 36 common pathways. Two genes, APOE and PVLR2, were 
significantly associated with CSF Aβ1-42  and amyloid-β accumulation (PET) in the 
brain after multiple comparison adjustments (Table 16). 
 
Table 16.  Gene-based association analysis of genes linked to the enriched 
neurogenesis-related pathways 
 
 
 
 
 
 
 
 
 
Gene 
N=1,272 
Corrected p-value 
(CSF Aβ) 
Corrected p-value 
(Amyloid PET) 
APOE 6.07 x 10-27 1.13 x 10-29 
PVRL2 1.07 x 10-16 3.48 x 10-21 
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36 pathways were common related to CSF t-tau, CSF ptau, CSF Aβ1-42 and 
amyloid-β accumulation in the cortical region (Figure 15). Interestingly, common 
pathways were related to neuronal process, neurogenesis, cell-cell adhesion, 
signaling transduction, lipid homeostasis as well as learning and memory. Gene-
based association analysis identified two novel genes, APOE and PVLR2, 
significantly associated with AD pathology. 
 
 Figure 15. Conceptual classification of pathways enriched in the AD 
pathology-related endophenotypes. 
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D. Discussion: 
 
In this study, using AD pathology-related endophenotypes measured by CSF and 
PET scans as phenotypes in the sample of CN, SMC, MCI and AD patients in 
ADNI, we performed genome-wide pathway analysis and identified GO Ontology 
pathways with enrichment for AD-related phenotypes.  
 
Tau protein enhances microtubule assembly and stabilization, and plays a crucial 
role in the establishment of the neuronal polarity and migration of the precursor 
neuronal cells in embryonic stage in axonal transport and in intracellular 
trafficking [333, 344-347]. The accumulation of the hyperphosphorylated 
microtubule-associated protein tau (MAPT) leads to tauopathies such as AD. 
Phosphorylation of the tau changes developmentally, and it is higher in fetal 
stage and reduces by aging [26, 348, 349]. In addition, p-tau is co-expressed 
temporally and spatially with DCX, a marker for neural precursor cells and 
immature cells, and NeuroD, differentiation marker, in the dentate gyrus of the 
hippocampus during postnatal development [293, 350, 351]. Adult neurons 
express tau with three microtubule-binding domains (tau-3R) and can be a new 
marker to identify new axons in SGZ [352, 353]. Tau-3R enables DCX expressed 
cells migration from the SGZ to upper layers and send axons into the CA3 
regions via dynamic microtubule network [24]. These results may suggest that 
there is a significant association between p-tau and adult neurogenesis. 
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Spatial/temporal control of tau phosphorylation can be compensatory mechanism 
for the neuronal loss in neurological disorders, including AD. However, tau 
knockout mice have the impairment in the morphological and synaptic maturation 
of newborn hippocampal granule neurons under basal conditions [334]. 
Genetically modified human tau expressed mice model showed that there is the 
deduction of the adult neurogenesis in the brain by as early as 2 months of age 
because of the reduction of the proliferation of precursor cells, before the 
development of tau pathology. In addition, the altered phosphorylation of the tau 
protein with neurogenic precursors was found in mice with tauopathy during 
neurogenesis [293].  
 
On the other hand, when adjusted by the APOE 4 allele status for gene-set 
enrichment pathway analysis, most of the neurogenesis related pathways were 
not among enriched pathways for CSF tau levels. Neural stem/progenitor cells 
express APOE in the adult brain. APOE knockout mice showed approximately 
60% lower adult neurogenesis in the dentate gyrus of the hippocampus than the 
wild type mice [339]. However, the maturation and the dendritic development of 
the newborn neurons in the hippocampus were significantly inhibited in the 
apoE4 knock-in mice because of the GABAergic interneuron dysfunction in the 
dentate gyrus while astrogenesis was stimulated in APOE4 knock in mice in the 
hippocampus. Under the stress, neurons expresses more APOE in the APOE4 
knock in mice than wild type and generates neurotoxic fragments via proteolytic 
cleavage. These neurotoxic fragments may cause the detrimental effect on 
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GABAergic interneurons and this effect can be reduced by lowering the 
endogenous tau [354-356]. Interestingly, These APOE4 neurotoxic fragments 
can increase tau phosphorylation especially in the GABAergic neurons, one of 
the hallmarks of AD [339, 357]. Our result confirmed the relationships among 
APOE genotype status, amyloid-β load, and neurogenesis. 
 
APP, PS1 and PS2 play crucial roles in neural stem cells proliferation, 
differentiation, maturation and survival while Arole is still unclear in adult 
neurogenesisHowever, some studies showed that the reduction of the Aβ levels 
and amyloid deposition enhances adult neurogenesis in mice model [210, 358, 
359]. 
 
As a result, the present results provide several new insights into key functional 
pathways associated with AD pathology-related phenotypes such as tau and 
amyloid-β in older adults with MCI or AD. Our gene-set enrichment analysis 
results highlight several candidates for further analysis of SNPs, genes, and 
gene sets underlying AD pathology and neurogenesis. 
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V. Conclusion and Future Directions 
 
In this project, we evaluated the potential modulators of adult neurogenesis and 
their roles in neurodegenerative diseases. We highlighted five important 
modulators of neurogenesis including signaling transduction pathways, the 
vascular and immune systems, metabolic factors, and epigenetic regulation using 
a systems biology approach. The alteration in these modulators during adult 
neurogenesis may be related to the development of neurodegenerative diseases 
such as Alzheimer’s disease. A more complete understanding of the role and 
function of each modulator in regulating NSC fate and integration of neurons in 
the SGZ and olfactory bulb may provide crucial insights leading to new therapies 
for neurological diseases in humans.  
 
Disruption of adult neurogenesis processes contributes to neurodegenerative 
diseases including AD and many of the molecular players in AD are also 
modulators of adult neurogenesis. However, the genetic mechanisms underlying 
adult neurogenesis in AD have been under-explored. To address this gap, we 
performed a gene-based association analysis in cognitively normal and impaired 
participants using neurogenesis pathway-related candidate genes curated from 
existing databases, literature mining, and large-scale genome-wide association 
study findings. Using targeted neurogenesis pathway-based gene analysis, we 
discovered a significant association of ADORA2A rs9608282-T with larger 
hippocampal volumes and volumes of neurogenesis-related hippocampal sub-
 131 
regions, better episodic memory performance, and reduced CSF total tau levels. 
Our findings suggested a protective effect of this SNP on brain structure and 
function in neurogenesis-related brain regions. We also examined the interaction 
of treatment with Memantine, a NMDA-receptor antagonist, and ADORA2A 
rs9608282 on hippocampal volume and memory performance. Combining three 
independent cohorts in a meta-analysis to enhance statistical power, we found 
that hippocampal volume was significantly associated with ADORA2A. The eQTL 
analysis using the BRAINEAC brain tissue microarray-based gene expression 
database (http://www.braineac.org/) revealed that rs9608282 in ADORA2A is 
marginally associated with ADORA2A gene expression level in the hippocampus 
(p-value = 0.172). Individuals carrying minor allele rs9608282-T have decreased 
expression levels in the hippocampus, showing a potential protective effect 
similar to our SNP-based association results with hippocampal volume and 
memory. Increased ADORA2A levels lead to synaptic toxicity and memory 
impairment [289-291]. Functional studies are needed to identify the mechanistic 
role of the highlighted SNP. However, the present findings support the 
ADORA2A gene playing a role in adult neurogenesis and AD. The association 
with hippocampal volume indicates the potential importance of further 
investigation of this gene, especially within in independent cohorts. 
 
Our gene-set enrichment analysis on genome-wide association studies (GWAS) 
from the Enhancing Neuro Imaging Genetics through Meta-Analysis (ENIGMA) 
consortium and Alzheimer’s Disease Neuroimaging Initiative (ADNI) showed that 
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neurogenesis-related pathways were associated with hippocampal volume and 
hippocampal atrophy. Enriched biological processes included neurogenesis, 
generation of new neurons, neuronal development, neuronal migration, 
differentiation and development, glutamate receptor activity, cell-cell adhesion, 
and synaptic transmission. Among genes that were highly-represented in these 
enriched pathways, we found TESC and ACVR1 were significantly associated 
with hippocampal volume after multiple comparison adjustment. In addition, using 
WGCNA, correlated gene expression analysis identified six significant network 
modules related to process of neurogenesis. We discovered that hippocampal 
volume is a potential phenotype for investigation of neurogenesis.  
 
It is also noteworthy that neurogenesis-related pathways which drive neural stem 
cell proliferation, maintenance in the adult neurogenic niche, and differentiation 
into mature neurons, were significantly enriched for tau and amyloid-β deposition 
in the brain. Interestingly, we observed common neurogenesis-related pathways 
enriched with hippocampal volume, tau and Aβ burden. . Our results suggest that 
neurogenesis related genes and pathways affect the formation and maintenance 
of hippocampal structure and memory and may play a role in atrophy and 
memory impairment in AD.  
 
In summary, we found three novel genes and variation related to adult 
neurogenesis as well as AD pathology. Since adenosine controls the pial 
vasodilation in the cerebral vasculature through binding of A2A receptors 
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secondary to endogenous production and the widening of blood vessels, 
ADORA2A plays an important role in vascular system. Also, that the adenosine 
2a receptor localizes in microglial cells and may be a regulation of microglial 
function in response to brain damage highlights the potential importance of 
ADORA2A in immune response. The other novel gene TESC is a potential target 
of class I histone deacetylase, important for epigenetic regulation, and inhibitors 
in neurons [360]. The last novel finding gene PVLR2, cell-cell adhesion gene 
Nectin-2, controls T-cell signaling by binding the co-stimulatory receptor DNAM1 
(CD226) and stimulates proliferation of T-cells and cytokines production [361]. 
The genetic variation in neurogenesis-related genes may play an important role 
in alteration of neural stem cell differentiation into new born neurons during adult 
neurogenesis with important therapeutic implications for AD (Figure 16). 
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Figure 16. Schematic illustration of three novel genes (ADORA2A, TESC 
and PVLR2) in impaired neurogenesis in neurodegenerative diseases 
 
 
Recently, studies focused on understanding mechanism of hippocampal 
neurogenesis using stem cells and cell cultures/tissue cultures. Many intrinsic 
and extrinsic signals impact neural stem cells proliferation, differentiation, 
migration and survival of new born neuros and their integration into neuronal 
circuitry during adulthood. Neural stem cells might use the treatment of 
neurodegenerative diseases including Alzheimer’s disease. Neurotrophins are 
growth factors and promote NSCs proliferation as well as differentiation [362]. 
Recently, Neurotrophin-3 (NT-3), important for survival, differentiation and 
migration, and gene transfection, promotes the in vitro proliferation and 
differentiation of bone marrow derived NSCs into cholinergic neurons [363].  
Since NSCs are located specific regions in the brain such as subventricular 
region of dentate gyrus and subventricular zone of olfactory bulb during 
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adulthood, targeting these NSCs into new neurons might be potential treatment 
of AD. The other stem cell study showed that administration of human umbilical 
cord blood-derived mesenchymal stem cells (hUCB-MSCs) into the hippocampus 
in AD mouse model reduced amyloid-deposition and enhanced adult 
neurogenesis through secreted growth differentiation factor-15 (GDF-15) [364]. In 
addition, the inducement of 5-HT receptors in mouse model stimulates adult 
neurogenesis through differentiation of induced pluripotent stem (iPS) cells into 
NPCs through activation of PKA and CREB pathways. iPS cell therapy may be a 
valuable source of NPC production to enhance adult neurogenesis for the 
formation of the newborn neurons in adult brain. A 3D culture system of 
hippocampal neurogenesis from hippocampal tissue in a mouse model was 
established using air liquid interface (ALI) culture and Matrigel culture [365]. The 
3D culture of hippocampus tissues might be a novel in vitro tool to understand 
the mechanism of neurodegenerative diseases and the process of hippocampal 
neurogenesis. 
 
Most importantly, our project yielded a small list of confirmed candidate gene 
variants that can be brought forward for experimentally molecular and functional 
validation in model systems. Development of murine models that carry top 
candidate variants we identified in this study would help provide a better 
understanding of the effect of these variants. The resources of the IU/JAX Model 
Organism Development and Evaluation for Late-onset Alzheimer’s disease 
(MODEL-AD), a recently established center to create novel animal models of AD 
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would be extremely helpful in advancing mechanistic follow-up studies. MODEL-
AD is co-led by investigators at Indiana University and the Jackson Laboratory 
(JAX). The involvement of my mentors and committee members in the MODEL-
AD center will further ensure a seamless transition and expansion of this project. 
Roles of specific variants and genes will be assessed by submitting novel 
candidates to MODEL-AD and JAX to develop new mouse models of late-onset 
AD. 
 
In addition, we note that vascularization and neurotrophic factors are major 
players in adult neurogenesis that are crucial for the NSC proliferation, 
differentiation, and their cell fate. Association analysis of cerebral blood flow with 
neurotrophic growth factor genes and brain-connectivity related phenotypes 
extracted from the diffusion tensor imaging of the brain (DTI) with neurogenesis-
related genes could be helpful for discovering additional novel candidate genes 
related to adult neurogenesis [366, 367]. We plan to perform an association 
analyses of brain-connectivity related phenotypes extracted from DTI with 
neurogenesis-related genes. 
 
Hopefully these insights regarding the role of neurogenesis in Alzheimer’s 
disease will contribute to a better understanding of AD and the quest for effective 
treatment and ultimately prevention of this important disease. 
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